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Abstract
Developing microbial systems capable of converting low cost lipids into value added
products depends on the ability to acquire substrates from the growth media. Saccharomyces
cerevisiae can acquire free fatty acids from the growth media and a portion of these lipids can be
converted into new lipid products. However, they cannot acquire complex lipids from the
growth media unless a nonspecific lipase is included. To circumvent lipase addition, we are
genetically engineering S. cerevisiae to secrete a lipase into the growth media. We selected the
LIP2 gene from Yarrowia lipolytica, which encodes a nonspecific lipase. Several modifications
were made to the LIP2 gene to improve processing. Results identified strains secreting the most
lipase. From these results, high producing strains were inserted into an oil inducible vector.
Halo assays confirmed lipase secretion, while measuring the fatty acid composition confirmed
triacylglycerol breakdown, and yeast uptake of the free fatty acids released.

Keywords; Metabolic Engineering, Saccharomyces cerevisiae, lipase, yeast, carboxypeptidase Y,
KEX2 protease, codon optimization, fatty acid methyl esters

viii

Introduction
Metabolic Engineering
Metabolic engineering is the directed improvement of cellular properties through
modification of specific biochemical reactions, introduction of new reactions and the application
of genetic engineering (Stephanopoulos 1998; Ostergaard 2000). The science of metabolic
engineering builds on a combination of traditional strain improvement and modern molecular
biological tools. The specificity of the biochemical reactions targeted for modification is key.
Once reactions and pathways are identified, molecular genetic techniques can be applied for
amplification, deletion, inhibition, regulation, secretion of proteins or transfer of the gene for the
enzyme. Metabolic engineering emphasizes the creation and introduction of integrated
metabolic pathways as opposed to focusing on individual reactions. As a field, metabolic
engineering is concerned with complete biochemical reactions, pathway synthesis, feasibility and
control. This discipline has enormous potential for enhancing the production of desired
metabolites from inexpensive sources.
A metabolic engineering strategy generally consists of two parts: analysis and synthesis.
Analysis is the identification of potential targets and a thorough working knowledge of the
genes, metabolites and features inherent to the cell in question. Potential targets are usually host
organisms that allow for easy evaluation of responses to the new metabolic pathway. Synthesis
is the genetic modifications of the organism and construction of recombinant strains with
improved properties. Cellular targets for metabolic engineering include substrate and product
range extension, productivity and yield improvement, by-product elimination, performance
improvement, property enhancement or creation and heterologus protein production (Ostergaard
et al. 2000; Cameron and Tong 1993).
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Figure 1-1: Various aspects of metabolic engineering, divided between analysis and synthesis
(figure from Ostergaard et al 2000).
For metabolic engineering to be successful, there are some requirements. First, a robust
host organism must be chosen. Host selection is based upon the availability of cloning vectors
and the ease of cloning, pathogenicity, substrate range, hardiness, availability of physiological
and genetic information, availability of regulatory mutants and the ability to use inexpensive
nutritional sources. Furthermore, the use of organisms that are generally regarded as safe
(GRAS) is desirable. Gene selection is also a vital part of a successful engineering strategy.
2

Selection of a gene is governed by availability of the gene, pathway requirements and
construction, enzyme kinetics, thermal stability of the protein, gene complexity, cofactor
requirements, regulatory properties and enzyme-enzyme interactions (Cameron and Tong 1993).
Identification of the optimal genetic changes requires meticulous examination of gene expression
and cellular metabolism at different conditions and the appropriate application of metabolic
engineering to optimize metabolism and expression. The tools used in metabolic engineering
include molecular biological tools (transformation systems, cloning vectors, promoters and
genetic markers), analytical chemistry tools (mass spectrometry, isotope labeling, NMR and flow
cytometry) and mathematical and computational tools (theoretical yield formulas, pathway
synthesis algorithms, and kinetic calculations) (Cameron and Tong 1993).
While yeast is eukaryotic and more genetically complex than E.coli, yeast has some of
the same useful qualities that make it a suitable research organism. Qualities such as rapid
growth, easy replication and mutant isolation, fully characterized genome and versatile DNA
transformation systems have made yeast a popular and successful model system for modern
biology. Saccharomyces cerevisiae, commonly known as baker’s yeast or budding yeast, is one
of the most thoroughly investigated eukaryotic organisms. It is a desirable laboratory organism
because it is non-pathogenic, generally regarded as safe, inexpensive to grow and maintain,
viable with numerous auxotrophic selectable markers, susceptible and amenable to genetic
modifications by recombinant DNA technology, and the total sequence of chromosomal DNA is
available.
Lipids and Fatty Acids
Lipids are a large and diverse group of biological compounds, related by their solubility
in nonpolar organic solvents and general insolubility in water. Lipids perform three major
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functions in the cell. They are major components of biological membranes, and also serve as
energy storage and intra- and intercellular signaling molecules (Voet et al. 1999). Cellular lipids
are divided into five distinct categories: fatty acids, triacylglycerols (TAG),
glycerophospholipids, sphingolipids and steroids. Fatty acids are the basic building blocks of
more complex lipids. TAGs function as storage lipids, alternate energy storage, and a source of
fatty acids for membrane phospholipid formation. Glycerophospholipids, cholesterol and
sphingolipids are structural components of cellular membranes.

Figure 1-2: Composition of a triacylglycerol (TAG). TAGs are composed of glycerol and three
fatty acid molecules linked by ester bonds. Lipases hydrolyze the reverse reaction.

Figure 1-3: Fatty Acids native to Saccharomyces cerevisiae
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Lipases
Lipases (triacylglycerols-acylhydrolases, EC 3.1.1.3) are water-soluble enzymes that
catalyze the hydrolysis of triacylglycerols in a heterogeneous reaction. The reaction can be
summarized by the following equation: Triglyceride ↔ Glycerol + Fatty acids. Another name
for lipases is lipolytic enzymes, which are capable of hydrolyzing ester bonds of lipid substrates
(Svendsen 2000). The lipase reaction occurs at an oil/water interface. The interface is usually
provided by emulsion globules or lipoprotein particles (Jensen et al. 1983). Lipases have
applications in several fields of industry including manufacture of foods, leather, cosmetics and
pharmaceuticals.
Lipases occur naturally in plants, animals and microorganisms (Vakhlu and Koor 2006).
Lipases function to catalyze hydrolysis of triglycerides to glycerol and fatty acid. The majority
of yeast lipases are extracellular, monomeric glyceroproteins with molecular weights ranging
from ~33 to ~65 kD (Vakhlu and Koor 2006). Lipases catalyze a wide range of reactions,
including hydrolysis, inter-esterification, alcholysis, acidolysis, esterification and aminolysis.
They also catalyze the hydrolysis of fatty acid ester bond in the TAG and release free fatty acids
(FFA).
Lipases are localized to different portions of the cell (or tissue) according to their
physiological functions. Generally there are two classes of lipases: soluble and membrane
bound. Membrane bound lipases are found in the cell wall and at the outer surface of the
cytoplasmic membrane (Ota et al. 1982). Their primary function is the mobilization of lipid
storage reserves. Soluble lipases are intra and extracellular. Intracellular soluble lipases are
associated with cellular growth functions at specific phases (Pereira-Meirelles et al. 2000).
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Extracellular soluble lipases are secreted into the growth media. Cells secrete lipases in order to
break down TAGs in their environment for uptake and use in cellular processes.
Lipases from various sources have wide variations in their reaction specificities. Specificity
of lipases is controlled by the molecular properties of the enzyme, structure of the substrate and
factors affecting binding of the enzyme to the substrate. Types of specificity include substrate,
positional, fatty acid, stereospecificity or combinations thereof. Substrate specificity describes
the differing rates of hydrolysis for triglyceride, diglycerides and monoglycerides. Positional
lipase refers to the position of the fatty acid cleaved off of glycerol; some lipases can cleave the
primary, secondary or all three ester bonds, exhibiting nonspecific hydrolysis (Jensen et al.
1983). Lipases most often cleave the fatty acids at the 1 or 3 position of glycerol or both, but not
the 2 position. Some lipases prefer cleaving the short-chain fatty acids (C2,4,6,8,10), unsaturated
fatty acids (oleic, linoleic, linolenic, etc) or randomly cleaving the fatty acids from the
triglyceride in a non-specific fashion (Ghosh et al. 1996). Lipase stereospecificity describes
faster hydrolysis of one primary sn ester as compared to the other. If the lipase is stereospecific,
the sn-1,2- or 2,3-enantiomer will be the predominant substrate (Jensen et al. 1983).
Triacylglycerol lipases catalyze the hydrolysis of TAGs at their 1 and 3 positions to form
sequentially 1,2-diacylglycerols and 2-acylglycerols (Voet et al. 1999).
The LIP2 gene (GenBank Accession No. AJ012632) was isolated from the oleaginous
yeast Yarrowia lipolytica. Y. lipolytica is an obligate aerobic dimorphic ascomycete yeast that
naturally secretes large amounts of various metabolites. This yeast grows readily on
hydrophobic substrates such as alkanes, fatty acids and oils (Barth and Gaillardin 1997). Y.
lipolytica can utilize triglycerides as carbon sources and produce many lipases, including
extracellular, cell bound and intracellular lipases (Yu et al 2007). Lipase production depends on
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the media composition and environmental conditions (Guerzoni et al.2001). The LIP2 gene
encodes a 334 amino acid preproprotein that is responsible for most of the extracellular lipase
activity in Y. lipolytica. Lip2 is able to catalyze the hydrolysis of long, medium and short chain
triglycerides at high rates (Aloulou et al. 2007). The lipase has high activity in hydrolysis,
esterification and transesterification reactions (Yu et al 2007) Although LIP2 seems involved in
the use of TAG as a carbon source for the yeast, the finding that a knockout strain is still able to
use this source suggests the presence of other lipases in Y.lipolytica. Lip2 is secreted into the
culture medium while Lip1and Lip3 are thought to be intracellular lipases and Lip7 and Lip8 are
mainly associated with the cell wall (Aloulou et al 2007; Fickers et al 2005). The LIP2 gene has
a codon adaptation index of 0.246, indicating that it is a moderately expressed gene. The mature
protein is a 301 amino acid glycosylated peptide classified as a triacylglycerol hydrolase (EC
3.1.1.3). It is optimally active at 37°C and pH7 and degrades vegetable oils well. Lipase
expression is induced by olive oil and oleic acid and repressed by glucose (Pignede et al. 2000).
The LIP2 gene contains several processing motifs. The first 33 amino acids consist of a
endoplasmic reticulum (ER) signal sequence, followed by four dipeptides (X-Ala or X-Pro), a
short 12-aa proregion, a Lys-Arg dipeptide, and the mature 301-aa lipase. There are also two
potential signals for asparagine-linked glycosylation (Asn-X-Thr/Ser) (Yu et al. 2007). Protein
processing involves cleavage of the signal sequence and endoprotease processing. The precursor
protein is processed by a KEX2-like endoprotease. The signal sequence cleavage site has been
predicted to be after amino acid 17 by SignalP prediction. The Lys-Arg dipeptide is the putative
substrate of the KEX2 endopeptidase. Lip2p may be secreted via the signal recognition
dependant pathway and its maturation is dependent upon KEX2 like processing (Pignède et al.
2000).
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Figure1-4: The LIP2 gene isolated from Yarrowia lipolytica (A) Processing of Y.
lipolytica Lip2p. Shown are the putative 13-aa signal sequence (SS), followed by a stretch of
four dipeptides (DP), a short 12-aa pro region (PRO) including the Lys-Arg (KR) cleavage site
of the KEX2-like XPR6 endoprotease , and the mature 301-aa lipase. The diamonds indicate the
positions of the potential signals for asparagine-linked glycosylation (Asn-X-Thr/Ser). (B)
Sequence of the preproregion and the first 27 N-terminal aa of the mature lipase encoded by the
LIP2 gene from Y. lipolytica . The DNA sequence is shown togetherwith the predicted amino
acid sequence (three-letter code) and the N-terminal amino acid sequences (one-letter code) of
the lipases secreted. The vertical arrow indicates the confirmed pro-mature lipase processing
site, and the vertical lines represent the four X-Ala and X-Pro dipeptides which act as possible
substrates for dipeptidyl aminopeptidase activity (Pignede et al. 2000).
Yeast Lipid Biotechnology
Yeast was the first microorganism recognized over a century ago to accumulate lipids
(Leman 1997). Yeast has been widely and effectively used to produce high value
pharmaceutical polypeptides, industrial enzymes and vitamins (Veen and Lang 2004). Yeast can
8

be genetically modified to produce selected substances in relatively high amounts. Additionally,
S. cerevisiae has emerged as a viable and versatile host for the synthesis of lipid compounds of
high commercial interest (Daum et al. 1998). S. cerevisiae has received attention as a source of
lipid compounds and a model organism for multicellular eukaryotes, due to its similarity in
subcellular structure of several of its lipid biosynthetic pathways (Veen and Lang 2004). Yeast
has many advantages for lipid production because this organism (1) can produce lipids similar to
vegetable oils and fats (2) can be grown on cheap agronomical and industrial wastes (3) can
produce lipids at high rates in bulk using large capacity reactors and (4) produce products that
are relatively non-toxic (Jacob 1993). Microbial lipids and plant oils have similar characteristics
with regard to fatty acid distribution, triacylglycerol types and secondary metabolites.
Microorganisms are attractive alternate sources of lipids because of their enormous growth rates
on a variety of substrates, their ability to synthesize a variety of products and ease of genetic
manipulation (Ratledge 2002). Another advantage for choosing yeast as a target of lipid
engineering is the fact that lipid pathways have been well characterized and thoroughly described
(Veen and Lang 2004).
There are several strategies by which lipid modifications can be made. Rerouting
metabolic pathways under optimized growth conditions in the presence of higher amounts of
substrates or precursors, cloning and expression of specific, desired genes in yeast, conversion of
post production lipids by enzymatic conversion and chemical conversion, are all feasible
methods of yeast lipid modification (Jacob 1993). With any or all of the modification strategies
utilized, the total lipid can be harvested by extraction with solvent systems or secreted by the
yeast and purified from the growth media.
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Fatty Acid Metabolism in Yeast
Cellular fatty acids are derived from three sources: external supply, endogenous lipid
turnover and de novo synthesis and elongation. When de novo fatty acid metabolism is blocked
or cells must bypass the energy expensive synthesis reactions, yeast can utilize fatty acids
derived from the growth media. Formation of C-C bonds is a highly energy demanding process
(Tehlivets et al. 2007). Cell types with high levels of fatty acid metabolism (either degradation
or storage) transport exogenous fatty acids at higher rates than do to those with low levels of
lipid metabolism The processes governing the transport of fatty acids across the membrane are
distinct from the transport of hydrophilic substrates such as sugars and amino acids.
Investigations into fatty acid transport address three central issues: (i) the low solubility of fatty
acids under aqueous conditions; (ii) the physical and chemical parameters of fatty acids, which
allows them to readily partition into a lipid bilayer; and (iii) the identification of membranebound and membrane-associated proteins (Black and DiRusso 2003). The mechanisms
underlying fatty acid transport across the plasma membrane are poorly understood. Two
possible mechanisms have been identified. In one mechanism, fatty acid transport is
independent of membrane-bound fatty acid transporters and occurs by simple diffusion. This
model suggests that transport is primarily diffusional and is independent of membrane-bound
fatty acid transporters. Fatty acids bind to and diffuse through the lipid bilayer. Transport is
driven by concentration gradients generated by either intracellular utilization (import) or
extracellular fatty acid-binding proteins (export) (Zou et al. 2002). In the second, membranebound and membrane-associated proteins mediate fatty acid import and/or export. The second
model suggests that membrane-bound and membrane-associated proteins mediate transport.
Several lines of evidence favor the involvement of proteins in the transport mechanism, including
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studies showing that this is a regulated process. In addition, cell types with high levels of fatty
acid metabolism (either degradation or storage) transport exogenous fatty acids at higher rates
when compared with those with low levels of lipid metabolism (Fargeman et al. 2001and Zou et
al. 2002).
In S. cerevisiae, fatty acid import is saturable and dependent on Fat1p, a homologue of
the murine fatty acid transport protein, FATP. Four fatty acyl-CoA synthetases encoded by
separate genes have been identified in S. cerevisiae: Faa1p, Faa2p, Faa3p, and Faa4p. Fat1p
plays a role in very-long chain (C22-C26) acyl-CoA synthetase activity, a pivotal role in long
chain fatty acid import. Faa1p and Faa4p are the primary enzymes involved in activation of
imported long-chain fatty acids (C12–C18) while Faa2p appears to be involved in activation of
medium-chain fatty acids directed toward peroxisomal β-oxidation. The physiological role of
Faa3p, which is most active toward fatty acids larger than C18, has not yet been defined
(Fargeman et al. 2001).

Figure 1-5: Schematic representation of fatty acid metabolism (Tehlivets et al 2007).
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Glycerolipid Biosynthesis (TAG Formation)
Glycerophospholipids, which include phospholipids and triacylglycerols, are essential
biomolecules. Phospholipids are the major component of membranes and determine membrane
permeability and modulate the activity of membrane proteins. TAG by contrast, is the major
storage form of energy. In yeast TAGs are synthesized through two pathways controlled by the
acyl-CoA diacylglycerol acyltransferase Dga1p and the phospholipid diacylglycerol
acyltransferase Lro1p. Formation of TAG requires the synthesis of phosphatidic acid (PA) and
diacylglycerol (DAG), two key intermediates of lipid metabolism. The endoplasmic reticulum
and lipid particles (LP) are TAG storage compartments in yeast and are the major sites of TAG
synthesis (Sorger and Daum 2003).
The major de novo biosynthetic pathways that yield PA utilize glycerol-3-phosphate (G3-P) or dihydroxyacetone phosphate (DHAP) as precursors. G-3-P is acylated by G-3-P
acyltransferase (GAT) at the sn-1 position to form 1-acyl-G-3-P (lyso-phosphatidic acid, LPA),
and then by 1-acyl-G-3-P acyltransferase (AGAT) in the sn-2 position, yielding PA. DHAP is
acylated at the sn-1 position by DHAP acyltransferase (DHAPAT), and the product 1- acylDHAP formed is reduced by 1-acyl-DHAP reductase (ADR) to yield LPA, which is further
acylated to PA by AGAT. PA can also be formed from phospholipids through the action of a
phospholipase D, or by phosphorylation of DAG through DAG kinase. Activation of PA with
CTP by a CDP-DAG synthase leads to the formation of CDP-DAG, the precursor for
phosphatidylinositol, phosphatidylglycerol, cardiolipin, phosphatidyl- serine,
phosphatidylethanolamine (PE), and phosphatidylcholine (PC). Dephosphorylation of PA by a
phosphatidate phosphatase (PAP) yields DAG, which is also formed from TAG by TAG lipases
or from phospholipids through the action of a phospholipase C. Acylation of DAG to yield TAG

12

is catalyzed by the two yeast proteins Dga1p and Lro1p, which utilize acyl-CoA or
phosphatidylcholine as acyl donors. DAG is a precursor for aminoglycerophospholipids via the
Kennedy pathway and therefore a key intermediate in membrane lipid biosynthesis and substrate
to diacylglycerol acyltransferases (DAGATs), which convert DAG to TAG using different acyl
donors (Wagner and Daum 2005; Dircks and Sul 1999; Sorger and Daum 2003).
Fatty Acid Storage
Fatty acids taken up by yeast are not stored as free fatty acids. FA esterified and stored
as triacyglycerols. TAG are the most important storage form for energy and fatty acids required
for the synthesis of complex membrane lipids in eukaryotic cells. In S. cerevisiae, formation of
TAG can occur through various pathways with the contribution of different enzyme. Since TAG
and steryl esters (STE) are unable to integrate into phospholipid membrane bilayers, they cluster
and form the hydrophobic core of lipid particles. The hydrophobic core of yeast lipid particle is
formed from TAG and STE and sequestered from the cytosolic environment by a phospholipid
monolayer with a small amount of characteristic proteins embedded (Daum et al. 2007).
The current model of lipid particle biogenesis is based on a budding hypothesis.
According to this model, proteins involved in neutral lipid metabolism including enzymes of
TAG and STE formation accumulate in certain regions of the ER. Neutral lipids newly formed
in these domains are unable to integrate into bilayer membranes and cluster in the hydrophobic
region between the two leaflets of the ER membrane. During ongoing synthesis of TAG and
STE the neutral lipid droplet grows and forms a bud. After reaching a certain size, the mature
lipid particle buds off the ER and is released into the cytosol. Mechanisms and metabolic
pathways appear to exist which allow the cell to grow lipid particles. With the exception of a
few enzymes, lipid particles in S. cerevisiae harbor the whole set of proteins required for de novo
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TAG formation including enzymes of fatty acid activation, PA synthesis and DAG acylation.
lipid particle may, however, not only serve as a storage compartment for neutral lipids. It has
been shown that neutral lipids of lipid particles may also play a role in stabilization of proteins.
Once inside a lipid particle, TAG and STE can be rapidly mobilized to fulfill the cell's
requirement for sterols and fatty acids. Hydrolysis of TAG by yeast lipases provides fatty acids
and DAG for the biosynthesis of complex membrane lipids (Daum et al. 2007).
Fatty acid desaturases modify fatty acids by endogenous or transgenically expressed
enzymes. Fatty acid desaturases are enzymes that convert a single bond between two carbon
atoms to a double bond in fatty acyl chains. Unsaturated fatty acids in glycerolipids are
important for the maintenance, structure and function of biological membranes. Each fatty acid
desaturase introduces an unsaturated bond at a specific location in a fatty acyl chain (Los and
Murata 1998).
While not an oleaginous yeast, S. cerevisiae has the potential to be oleaginous. An
oleaginous species can accumulate between 30 – 70% of its total biomass in triacylglycerols as
cellular storage lipids. Dyer et al. (2002) found that cultivation of yeast cells in media containing
fatty acids as a sole carbon source increased the uptake of free fatty acids and increased total
cellular lipid content sevenfold. Yeast cells grow very poorly on fatty acids, as evidenced by the
slow metabolism of fatty acids and increase in doubling time from 1-4 hours to 20 hours. To
help improve cellular capacity to degrade fatty acids to carbon metabolites (e.g., acetyl-CoA),
the yeast cells respond by proliferating the number of peroxisomes in the cell (Trotter 2001). In
addition, cells transcriptionally up-regulate the genes encoding enzymes of peroxisomal βoxidation, the main pathway for degrading fatty acids (Hiltunen et al. 2003).
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Fatty Acid Induction of Gene Expression
When glucose is depleted, a number of genes are expressed through glucose derepression
(Trotter 2001). However, other genes obey additional cues relating to nutritional availability.
For example, β-oxidation genes are repressed by glucose, derepressed on non-fermentable
carbon sources, and are induced several fold in the presence of oleic acid. This oleate induction
is accompanied by a drastic expansion of the peroxisomal compartment. (Gurvitz and
Rottensteiner 2006). Peroxisome biogenesis and function is induced by exposure to fatty acids.
In yeast, expression of such peroxisomal proteins is subject to several types of regulation,
primarily at the level of transcription. When cells are cultured in medium containing 2%
glucose, the enzymatic activitiy is nearly undetectable, but growth in a nonfermentable carbon
source causes these activities to rise by 20 times. Exposure to oleic acid increases the activities
of these enzymes further 20-fold (Trotter 2001; Gurvitz and Rottensteiner 2006).
Peroxisomes are cellular organelles that house enzymes that are involved in fatty acid β–
oxidation. Yeast degrades fatty acids only in the peroxisome. Peroxisomes are characterized by
the presence of oxidative enzymes such as catalase and peroxidase. Transfer of S. cerevisiae
from a medium containing glucose to a medium containing fatty acids as the sole carbon source
is accompanied by marked physiological changes. When grown in the presence of fatty acids
yeast cells upregulate genes involved in fatty acid metabolism, increase the size and number of
peroxisomes, and change cell structure (Smith et al. 2006). Two genes are known to regulate
peroxisome multiplication, PEX10 and PEX11; both encode peroxisomal membrane proteins.
When overexpressed, these genes cause the rapid increase in the number of peroxisomes.
In β-oxidation, fatty acids are broken down to generate acetyl-CoA. Overall the process
involves four main steps: dehydrogenation, hydration, oxidation and thiolysis. The process
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repeats until the fatty acid has been completely degraded to acetyl-CoA. Each round of βoxidation yields 1 molecule of NADH, 1 molecule of FADH2, acetyl CoA and 2 carbon fatty
acid.
Yeast Secretory Pathway
Protein transport and secretion in eukaryotic cells involves a complex series of events
associated with membrane bound cellular components. Protein secretion in S. cerevisiae follows
a pathway that is similar to that of mammalian cells (Zsebo et al. 1986). S. cerevisiae has a
multicomponent secretory pathway making posttranslational modifications of heterologous
proteins possible (Ostergaard et al. 2000). Proteins are generally believed to move between the
compartments of the secretory pathway by budding and fusion of transport vesicles between
successive compartments. This method of transport maintains the distinct internal environments
of the cellular compartments (Atkinson 2006). The S. cerevisiae α factor prepro-leader
sequence is the most commonly used secretory expression system for heterologous proteins in
yeast. Fusion of the prepro leader sequence and a heterologus gene directs S. cerevisiae to
secrete heterologous proteins, since the leader sequence mediates cotranslational translocation of
the fusion protein into the endoplasmic reticulum. Once the DNA is transcribed into mRNA and
the mRNA is translated into protein, the secreted protein enters the endoplasmic reticulum (ER).
Once in the ER, proteins are folded and undergo modifications such as glycosylation, disulfide
bridge formation, phosphorylation and subunit assembly (Conesa et al 2001). The LIP2 gene
products undergo N-linked glycosylation. N-linked glycosylation involves the attachment of a
precursor oligosaccharide to the asparagines residue (Atkinson 2006). The proteins leave the ER
packaged in transport vesicles and travel to the Golgi compartment where additional
modifications can take place (Conesa et al 2001). The pre-region of the leader sequence is
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cleaved by a signal peptidase and the Kex2 endoprotease cleaves the pro-region in the Golgi
apparatus. Finally, the mature protein is packaged into secretory vesicles and directed to the
plasma membrane. The secretory vesicles then fuse to the plasma membrane, releasing the fully
processed protein into the extracellular space (Ostergaard et al. 2000). Some yeast proteins
accumulate in the periplasmic space rather than passing through the cell wall and into the culture
medium (Zsebo et al. 1986; Conesa et al 2001).

Figure 1-6: The Yeast Secretory Pathway. Proteins carry codes in their sequences that are read
by targeting machinery at every stage. Proteins may be targeted to the cytosol, mitochondria,
peroxisomes or chloroplasts. Proteins destined for secretion are synthesized on the membrane
bound ribosomes of the rough ER. They are then targeted to the appropriate cellular
compartment (Atkinson 2006).
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The Current Study
Dyer et al. 2002 provided the analysis portion of the metabolic engineering strategy and
set forth the elements for a lipid metabolic engineering strategy for S. cerevisiae. The strategy is
to culture cells in media containing fatty acids as the sole carbon source, thus causing
peroxisomal proliferation and fatty acid β oxidation. As a result of this growth strategy it was
proposed that S. cerevisiae could acquire and retain fatty acids, in the form of lipid droplets,
from the media and increase cellular lipid content from 2% to 15% dry weight. S. cerevisiae
cannot take up triacylglycerols (the main component of oils) from the growth medium, but can
do so if a nonspecific lipase is added to the growth medium to first break down the TAG into
fatty acid components. Dyer tested this hypothesis and showed that yeast cells grown in the
presence of TAGs and an exogenously added lipase results in TAG hydrolysis and uptake of the
fatty acid components of the TAGs. From these promising results, Dyer hypothesized that S.
cerevisiae could be engineered to secrete a nonspecific lipase for the hydrolysis of TAGs for the
subsequent yeast uptake of component fatty acids. Furthermore, he introduced a long range goal
of developing a microbial expression system for bioconversion of low cost lipids into value
added products (Dyer et al. 2002).
Hypothesis
We hypothesize that insertion of the LIP2 gene from Yarrowia lipolytica into a yeast
shuttle vector in Saccharomyces cerevisiae will cause the secretion of a nonspecific lipase into
the growth medium. Once secreted, the nonspecific lipase will breakdown triacylglycerols in the
growth media. Furthermore, modifications to the LIP2 gene will increase secretion in yeast
cells.
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Materials and Methods
Materials
DIFCO brand yeast media, yeast nitrogen base without ammonium sulfate and without
amino acids, tributyrin, linoleic acid, trilinolein, and Tween 20 were purchased from Fisher
Scientific (Hampton, NH). Synthetic complete amino acid supplement drop-out mix (SCMURA, -TRP) was purchased from Bufferad (Lake Bluff, IL). Restriction enzymes, enzyme
buffers, ligases, calf intestinal alkaline phosphatase (CIP), and DNA ladders were purchased
from New England BioLabs (Ipswich, MA). RNA molecular weight marker was purchased from
Roche Applied Science (Indianapolis, IN). TOPO cloning kits and chemically competent cells
were purchased from Invitrogen (Carlsbad, CA). All other chemicals, unless otherwise noted,
were purchased from Sigma-Aldrich (St. Louis, MO).
Yeast strains and growth conditions
Saccharomyces cerevisiae strain MMYO11α (MAT α ade 2-1 his3-11, 15 leu2-3, 112
tyr1-1 ura3-1 can1-100 Ole+) and its subsequent derivatives were used for these studies.
Untransformed yeast cells were maintained on YPD media (1% w/v yeast extract, 2% w/v
peptone, 2% w/v dextrose) solidified with 2% w/v agar. Transformed cells containing plasmids
were maintained on SD plates (2% w/v dextrose, 0.67% w/v yeast nitrogen base without amino
acids, 2% w/v agar) with appropriate amino acid supplements. Single colonies were inoculated
into SD liquid media and grown overnight at 30°C and 300 rpm. Cell growth was measured by
optical density (OD) of the cultures at 600 nm on a Beckman spectrophotometer.
Yarrowia lipolytica E122 strain was also used for this study. Untransformed yeast cells
were maintained on YPD media agar plates. Single colonies were inoculated in the same media
and grown in the same manner as detailed above.
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Recombinant DNA Protocols
E. coli transformations were performed using chemically competent cells (Invitrogen) or
the colony method bacterial transformation protocol (Dyer and Murai, 1991). Yeast
transformations were performed using the Quick and Easy Gietz method (1995). Plasmid DNA
was isolated using the Wizard Miniprep DNA purification system (Promega). DNA bands were
excised from 0.7% agarose gels and purified according to the Geneclean Gel Isolation and
Reaction Cleanup protocol (II) from Q-BIO gene. Site directed mutagenesis was performed
according to the Stratagene Quick Change Site Directed Mutagenesis protocol. DNA sequences
were verified using and a Beckman CEQ8000 capillary sequencer. Prior to sequencing, salt and
protein were removed from the sequencing reactions using cleanup cartridges from the Zymo
Research DNA Clean & Concentrator Kit. All other cloning procedures were performed as
described by Sambrook et al. (1989), with minimal modifications where necessary.
Plasmid Constructions
pYes2.1. pYES2.1/V5-His-TOPO is a 5.9 kb vector with the following features: 2 micron
origin of replication for high-copy plasmid maintenance, GAL1 promoter for galactose-inducible
expression of cloned genes, URA3 gene for prototrophic selection in host strains, C-terminal V5
epitope and polyhistidine (6xHis) tags for simplified detection and purification of the fusion
protein, CYC1 terminator sequence for efficient transcription termination and mRNA
stabilization, and an ampicillin resistance gene for selection of E.coli transformants.
Transcription from the GAL1 promoter is repressed in the presence of glucose and induced by
removing glucose and adding galactose as a carbon source (Invitrogen).
pYes2.1-LIP2 and pYes2.1-LIP2-V5/His (NS). A PCR reaction of Yarrowia lipolytica
E122 genomic DNA using LIP2Forward (5’GCCACCATGAAGCTTTCCAC CATCCTTTTC
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3’) and LIP2Reverse (5’CCTTAGATACCACAGACACCCTCGGTGA C 3’) primers was used
to isolate the LIP2 gene. The PCR reactions (L2) were prepared in standard form and thermal
cycled using Pfu polymerase and a 1 minute extension time corresponding to the 1kb fragment
size. The resulting reaction was run on a 0.7% agarose gel against a 1kb marker. PCR products
showing the highest concentration (as determined by band intensity) were isolated, cleaned and
cloned. 2 µl of L2 were cloned directly into pYes2.1 TOPO TA vector using 10 minute
incubation at room temperature (22°C). The cloning reaction was as follows: 2 µl L2, 1 µl salt
solution, 1 µl sterile water and 1 µl vector. The reaction showing the highest DNA concentration
was used for bacterial transformation. The remaining portion of the reaction was stored at 4°C.
pYes2.1-LIP2NS (reaction L2NS) was constructed in the same fashion as pYes2.1-LIP2, but
LIP2RevNS (5’GATACCACAGACACCCTCGGTGACGAAGT 3’) was the reverse primer
used to amplify the LIP2 gene from Y. lipolytica and pYes2.1/V5-HIS-TOPO vector for
subcloning. All open reading frames of LIP2 were built with and without the stop codon.
Removal of stop codon created C-terminal, V5-peptide fusion, which can be recognized by antiV5 antibody in western blotting.
pYes2.1-LIP2-opt: Since the LIP2 gene was isolated from Y. lipolytica, a codon
optimized version of the LIP2 gene was purchased from Genscript. The codons of the gene were
optimized for expression in S. cerevisiae. PCR was employed to remove the codon optimized
gene from the company vector (pUC57), and TOPO cloning was used to insert the gene into
pYes2.1 vector. The PCR reactions were prepared in standard form and thermal cycled using a 1
minute extension time corresponding to the 1kb fragment size. The resulting reaction was
isolated, cleaned and cloned. 2 µl of the reaction were cloned directly into pYes2.1 TOPO TA
vector.
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pYes2.1-LIP2SER and pYes2.1-LIP2-SERNS:

A modified LIP2 gene was produced to

optimize the propeptide cleavage site for the S. cerevisiae Kex2 protease. To accomplish this, a
serine codon was inserted into the LIP2 gene at position adjacent to the KEX2 cleavage site.
This insertion was created using site directed mutagenesis with pYes2.1-LIP2 and pYes2.1LIP2NS plasmids as templates. For insertions 18 reaction cycles and 12 minutes (2 minutes/kb
plasmid) extension was used for this reaction. The insertion was introduced using the following
primers: SERTop (5’GCCGCAGTTCTCCAGAAGCGA TCTGTGTACACCTCTACCGAGA
CC 3’) and SERBottom (5’GGTCTCGGTAGAGG TGTACACAGATCGCTTCTGGAGAACT
GCGGC 3’). Following PCR-mediated mutagenesis, template plasmid DNA was digested using
DpnI and the resulting PCR reaction was transformed using chemically competent DH5α cells
and incubated overnight at 37°C on LB-Amp agar plates. Single colonies were inoculated into
liquid LB-Amp, cultured overnight and plasmid DNA was extracted using the Promega Wizard
miniprep kit. The plasmids were sequenced using the GAL1 forward primer (5’AATATACCTC
TATACTTTAACGTC 3’).
To replace the LIP2 gene with LIP2-SER gene in pYes2.1-LIP2 and pYes2.1-LIP2NS,
three restriction digests were performed. pYes2.1-LIP2, pYes2.1-LIP2NS and pYes2.1LIP2SER were digested with PvuII and SacI at 37°C for 2 hours. The vector portion of pYes2.1LIP2 and pYes2.1-LIP2NS as well as the LIP2-SER insert were isolated from the agarose gel
and genecleaned. The plasmids were screened by restriction analysis for the correct digestion
pattern. The vector and insert portions were then ligated and transformed using the colony
method bacterial transformation protocol. Plasmids showing the highest concentrations were
selected for yeast transformation.
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pYes2.1-LIP2-CPY (LIP2-CPY-V5/His ): The LIP2 gene was modified by the
replacement of the prepro sequence of Lip2 with the carboxypeptidase Y (CPY) signal sequence
from S. cerevisiae. This construct was created using gradient PCR, pYes 2.1-LIP2, CPYLip2Fusion primer (5’CCATGAAAGCATTCACCAGTTTACTATGTGGACTAGGCCTGTCC
ACTACACTCGCTAAGGTGTACACCTCTACCGAGACCTCTC A 3’) and Lip2Reverse
primer. After PCR amplification, the fragment was genecleaned and transformed into bacteria.
The resulting plasmids (pYes2.1-LIP2CPY and pYes2.1-CPYNS) were sequenced. The
orientation of LIP2-CPY gene within pYes2.1 was confirmed using a PvuII/SacI double
restriction digest. A SacI site is unique to the CPY sequence.
To replace the LIP2 gene with LIP2-CPY gene in pYes2.1-LIP2 and pYes2.1-LIP2NS,
three restriction digests were performed. pYes2.1-LIP2, pYes2.1-LIP2NS and pYes2.1LIP2CPY (from gradient PCR) were digested with PvuII and SacI at 37°C for 2 hours. The
vector portion of pYes2.1-LIP2 and pYes2.1-LIP2NS as well as the LIP2-CPY insert were
isolated from the agarose gel and genecleaned. The vector and insert portions were then ligated
and transformed in bacteria, then yeast.
pEX11-424-LIP2-SER. pEX11-424 vector contains the TRP1 selectable marker.
pEX11-424-SER was created using restriction digests to open the vector and remove the LIP2SER gene from pYes2.1-LIP2-SER.
pEX11-426-LIP2, LIP2NS, LIP2-SER and LIP2-SERNS. pEX11-426 vector contains
the URA3 selectable marker. pEX11-426-LIP2-SER and pEX11-426-LIP2-SERNS were created
using restriction digests and custom PCR primers. To extract the LIP2 sequences from
individual pYes 2.1 vectors, PCR primers PEXLip2Forward (5’CAGAGAATTCGCCACCATG
AAGC TTTCC ACCATCCTTTTC 3’) and PEXLip2Reverse (5’ACTTCCCGGGCTCTTAGAT
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ACCACAGAC ACCCTCGGTGAC 3’) were created. These primers add restriction sites EcoRI
(forward primer) and XmaI (reverse) to the LIP2 genes as they are amplified out of the pYes2.1
vectors. These PCR reactions were run on a 1% agarose gel. The bands containing the
amplified LIP2 genes were isolated and genecleaned. Once the genes are amplified with new
restriction sites at both ends, the pEX11-426 plasmid was restriction cut with EcoRI and XmaI.
Following that the vector and insert fragments were ligated together. The resulting plasmids
were transformed into bacteria and yeast.
pEX11-426 LIP2-opt. In purchasing the codon optimized LIP2 gene, restriction sites
EcoRI and BglII were added to the 5’ and 3’ ends, respectively, of the gene. pEX11-426 and
pUC57 underwent restriction digest by EcoRI and BglII. The vector portion of pEX11-426 and
the LIP2 gene were extracted from agarose gel and ligated together. The resulting plasmids were
bacterial transformed and plasmids showing the highest concentrations (determined from agarose
gel band intensity) were selected for yeast transformation.
pEX11-426∆PstI. pYes2.1 was digested with PstI to liberate a 488 bp fragment that
included part of the URA promoter and 2 micron ori. Removal of this fragment from pYes2based vectors was previously shown to significantly increase the copy number of plasmids in
yeast cells. The digested pYes2.1 vector portion (pYes2.1∆) was then isolated from agarose and
self-ligated. pYes2.1∆ was then cut with SpeI and XbaI to remove the GAL1 promoter and CYC
terminator region, and treated with T4 DNA polymerase to generate blunt ends. The reaction
was run on an agarose gel and the vector portion was isolated by genecleaning. pEX11-426 was
restriction cut with KpnI and SacI, which released a DNA fragment that included the pEX11
promoter, polylinker and terminator. Following restriction digest the fragments were treated
with the blunt end protocol. The smaller fragment (pEX11 promoter, polylinker and terminator)
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was isolated from agarose gel and genecleaned. The pEX11-426 promoter/terminator fragment
was ligated to the blunt ended pYes2.1∆ plasmid. The resulting plasmid was composed of
pEX11-426 promoter/terminator fragment and pYes2.1 plasmid, without the PstI fragment.
of the plasmid constructs created for this study are summarized in Table 1.

Name

Functional Characteristics

pYes2.1

High copy (2 micron), URA, GAL promoter, CYC terminator

pYES2.1 LIP2
pYES2.1 LIP2NS

Native LIP2 lipase from Y. lipolytica

pYES2.1 LIP2 opt

Native LIP2 lipase, codon optimized

pYES2.1 LIP2-Ser
pYES2.1 LIP2-SerNS

LIP2 with improved Kex2 site

pYES2.1 LIP2-CPY
pYES2.1 LIP2-CPYNS

LIP2 with carboxypeptidase Y signal sequence

pEX11

Oil inducible vector, high copy (2 micron), PEX11 promoter and
terminator

pEX11-424, pEX11-426

TRP1 selectable marker, URA3 selectable marker

pEX 11-426 LIP2

Native LIP2 lipase from Y. lipolytica in oil inducible vector

PEX 11-426 LIP2-Ser

LIP2 with improved Kex2 site in oil inducible vector

PEX 11-426 LIP2-opt

Native LIP2 lipase, codon optimized

PEX11-426∆PstI

Ultra high copy constructed plasmid (Okkels 1996)

NS = No Stop, indicates V5/His tag at the C terminal end

Table 1: Overview of plasmid constructs.
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All

Cell culturing and lipid extraction
Preparation of individual synthetic galactose cultures for pYes-based plasmids.
Culturing of yeast cells containing pYes-based (galactose inducible) vectors was conducted over
the course of two days. On the first day, 50 ml synthetic dextrose – 10 X URA media was
inoculated with a single colony of yeast in a 250 ml flask. Cultures were grown 20 – 24 hrs at
30oC and 300 rpm. On the second day, the optical density of the culture at 600 nm (OD600) was
measured and the volume of culture representing 25 OD units was calculated and transferred to a
centrifuge tube. The cells were then spun in a swinging bucket rotor (SH-3000) for 10 minutes
and 4000 rpm at 25 - 28oC. The supernatant was discarded. The cells were resuspended in a
small volume of synthetic galactose media and transferred to 100 ml synthetic galactose – 10 X
URA media in a 500 ml flask (cell density was 25OD/100ml = 0.25 OD/ml). The appropriate
lipids (0.1% v/v), trilinolein or linoleic acid, were added to their respective cultures. The
cultures were then grown 20 – 24 hrs at 30oC and 300 rpm. On the following day the cultures
were harvested, spheroplasted and lipids were extracted as described below.
Preparation of individual Holland Minimal Yeast Media (HMY) cultures for pEX11based plasmids. Culturing of yeast cells containing pEX11-based (fatty acid inducible)
plasmids took place over the course of two days. The first day of culturing proceeded in the
same manner as those for pYes-based plasmids except the auxotrophic supplements were URA
(pEX11-426) and TRP (pEX11-424). The second day of culturing proceeded in the same
manner as previously described for pYes based vectors except the transferred cells were placed
in 100 ml synthetic glycerol dextrose –10X amino acid in a 500 ml flask. Cell density was
25OD/100ml = 0.25 OD/ml.. The cells were grown 20 – 24 hrs at 30oC and 300 rpm. On the
third day, the cultures were “boosted” by adding 10 ml of 10X yeast peptone (see Appendix B,
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Solutions). The cultures were returned to the same growth conditions for 4 hours. During that
time, HMY media was prepared for each culture in a 500 ml flask. The media consisted of 90 ml
HMY – 10X amino acids, 10 ml 10X amino acids, and 100 µl 1000X vitamins. After four hours
the OD600 of each culture was determined and the volume of culture for 100 OD of cells to
transfer was calculated. The cells were transferred to a centrifuge tube and spun in SH-3000 for
10 minutes and 4000 rpm at 25 - 28oC. The supernatant was discarded. The cells were
resuspended in a small volume of HMY and transferred to 100 ml of HMY-aa. Cells were
transferred to culture flasks (culture density is 100 OD/100 ml = 1 OD/ml). The appropriate
lipids (0.1% v/v), trilinolein or linoleic acid, were added to their respective cultures. The
cultures were then grown 20 – 24 hrs at 30oC and 300 rpm. On the following day the cultures
were harvested, spheroplasted and lipids were extracted as described below.
Cell harvesting. Cells were harvested during late-log or early stationary phase. Starter
cultures were grown overnight in synthetic dextrose media, then resuspended in synthetic
galactose media. After 18-22 hours at 30oC incubation, cells were harvested in late-log phase.
100 ml of yeast culture was harvested and centrifuged at 4000 rpm, 30oC for 10 minutes. The
supernatant was discarded and the pellet was resuspended by inversion in 30 ml sterile double
distilled water or 1% v/v filter sterilized Tween-40 and centrifuged again at 4000 rpm, 30oC for
10 minutes. The supernatant was then removed and discarded. The pellet was then resuspended
and washed with 30 ml sdd H2O and centrifuged at 4000 rpm, 30oC for 10 minutes. The
supernatant was aspirated and the pellet again resuspended in 20 – 30 ml water. 100 µl cells
were transferred to a labeled microfuge tube and OD600 was measured to determine the total OD
of the culture. The remainder of the culture was centrifuged as above and aspirated carefully.
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Preparation of spheroplasts. The aspirated cell pellet was resuspended in 10 ml 0.1 M
Tris-SO4 pH 9.2, 10 mM dithiothreitol (DTT), by inversion. The screw topped lids of the culture
tubes were loosened and taped into place. The culture tubes were incubated in a shaker for 15
minutes at 30oC and 300 rpm. The culture was then centrifuged at 4000 rpm, 30oC for 10
minutes. Once aspirated the cells were washed with 10 ml of 1 M sorbitol, centrifuged at 4000
rpm, 30oC for 10 minutes, aspirated and the supernatant removed. Cells were resuspended in 5
ml of 1 M sorbitol, 20 mM potassium phosphate, pH 7.5, and a calculated amount of Zymolyase20T solution (2 µg zymolyase/OD cells) was added to the cell suspension. The caps on the
culture tubes were loosened and held in place using tape as above and incubated 1 hour at 30oC
and 300 rpm. After 50 minutes, the progress of spheroplast formation was checked by osmotic
lysis. A 5 µl aliquot of cells was removed and viewed under a microscope. Next, 5 µl of water
was added near the cover slip and the cells observed for lysis. When approximately 70% of the
cells under the microscope were disrupted, the culture tubes were removed from the incubator
and transported on ice to the centrifuge. The spheroplasts were harvested by centrifugation as
above and the supernatant removed. Lipids were harvested immediately.
Lipid extraction (Bligh and Dyer 1959, plus washes, Revision of Zanolari et al.,
2000). The spheroplast pellet was resuspended in 300 µl of 1 M sorbitol. 400 µl of sdd H2O
was added and the suspension was vortexed briefly. 3 ml of chloroform/ methanol/ butylated
hydroxytoluene (BHT) (1:2 v/v, 0.01% BHT) was added. The container was flushed with
nitrogen, capped tightly and vortexed vigorously for 30 seconds. Each suspension was vortexed
three times for 30 second intervals for a total of 2 minutes/sample. The denatured protein and
cell debris were then pelleted by centrifugation at 4000 rpm, 30oC for 10 minutes. The
supernatant containing lipids was then collected and transferred to a labeled glass centrifuge tube
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(15 ml Corex II, #8441 or Kimax) with Nalgene push on caps or 15 ml red capped plastic
centrifuge tubes, flushed with nitrogen and capped tightly. The remaining pellet was
resuspended in 1ml chloroform/0.01% BHT, vortexed vigorously for 1 minute, and centrifuged
as described above. The supernatant was carefully aspirated from the solution and combined
with the first supernatant in the glass centrifuge tube or 15 ml red capped centrifuge tube. 1 ml
of 0.88% KCl was added to the combined supernate fractions to promote phase separation,
vortexed briefly and centrifuged for 5 minutes at 25oC and 2000 rpm. The upper
aqueous/methanol layer as well as any interfacial material that may be associated with this layer
was aspirated and discarded. The lower chloroform phase containing lipids was removed by
aspiration. The chloroform layer was filtered through glass wool and into labeled 4 ml amber
teflon capped vial and layered with nitrogen. Lipids were stored at –20°C.
Determination of lipid concentration. Labeled 1.5 ml serum vials were weighed and
recorded. 150 µl of the chloroform extract was transferred to the weighed vial and recorded.
The sample was evaporated under a stream of nitrogen. The weights of the vials were recorded
at intervals of 60 and 90 minutes or until constant. The weight of lipids in the vials was
determined and used to calculate the concentration of the original sample by dividing the weight
of dried lipid residue (mg) by 1.5 ml.
Gas Chromatography
Preparation of fatty acid methyl esters (FAME). An aliquot of lipid extract
representing 1 mg of lipid was transferred to glass screw capped tubes and the solvent was
evaporated to dryness under a gentle stream of nitrogen. Dried lipid extract was reconstituted in
1 ml hexane and vortexed 1 minute. 0.2 ml 0.5 M sodium methoxide in methanol (NaOCH3CH3OH) was added and the solution was vortex 1-1.5 minutes. The sample was incubated at
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room temperature for 10 minutes to transmethylate fatty acids. 3 ml saturated NaCl was added
to terminate the reaction and the mixture was vortexed 1 minute. 40 µl of 0.5 mg/ml methyl
heptadecanoate (C17:0) was added as an internal standard, along with 3 ml hexane. The solution
was vortexed 2 minutes and incubated at room temperature for 20 minutes or until clear phase
separation occurred. The hexane (upper) layer was removed and filtered through 1 g Na2SO4 and
into a clean 1 dram vial. Immediately before gas chromatography, the sample was concentrated
under nitrogen to a volume of 1 ml. The concentrated sample was transferred to auto sampler
vials.
Analysis of FAME. FAME were analyzed on an Agilent 6890N Gas Chromatograph. A
temperature program of 110–160°C at 15°C/minute, to 170°C at 5°C, then to 200°C at
22.5°C/minute with a final hold for 3.3 minutes was employed. FAME were identified by
comparison of retention times to FAME standards using methyl heptadecanoate as an internal
standard, and percent FAME was calculated based on peak area counts.
Halo Assay for Lipase Activity
Cell Culturing. Yeast cells were prepared as follows: Single colonies were inoculated
into SD liquid media and grown overnight at 30°C and 300 rpm. Cell growth was measured by
optical density (OD) of the cultures at 600 nm on a spectrophotometer. The volume of culture
representing 25 OD units was calculated and transferred to a centrifuge tube. The cells were
then centrifuged for 10 minutes and 4000 rpm at 25 - 28oC. The supernatant was discarded. The
cells were transferred to 100 ml synthetic galactose – 10 X URA media in a 500 ml flask.
Halo Assay. To qualitatively detect lipase activity, an agar plate assay was employed
(Pignede et al. 2000). The media used (per liter) was 1.7 g yeast nitrogen base without
ammonium sulfate and without amino acids, 4 g of ammonium chloride, 10 g tributyrin stock
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solution, and 100 ml 10X-amino acid. A stock solution of the triacylglycerol tributyrin was
composed of 20% tributyrin v/v, 1% Tween 20 v/v and subjected to sonication three times for 1
minute each on ice. Agar (2% w/v) was added for solid media formation (YNBT). Each halo
assay plate contained about 100 ml YNBT agar. The halo assay plates were poured 5-12 hours
before needed to prevent tributyrin pooling. 10 µl yeast cell culture was placed onto the agar. A
halo or clearing zone was visible after 36 - 48 hours of incubation at 30oC.
The LAS-3000 imaging system from Fuji Film Life Sciences (Tokyo, Japan), was used to
create images of the agar plates. The LAS-3000 imager combines a CCD camera with a user
interface. The Multi Gauge (version 3.0) software allowed for editing the saved images and
drawing lines onto the image through the center of the cell and halo (radii). The software
provides the length of the radii. The cell and the halo surrounding it can be defined as two
concentric circles. Once measured, the annulus calculation (Figure 3-9), provides a numerical
value for the region between the two circles (Weisstein, 2002).
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Results
Cloning LIP2 into Saccharomyces cerevisiae
The LIP2 gene from Y. lipolytica was isolated and amplified from genomic DNA and
cloned into the high copy yeast shuttle vector pYes2.1 (Figure 3-1), forming the plasmid
pYes2.1-LIP2 (Figure 3-2). This molecule was expected to secret the lipase protein into the
growth medium. A second version of this molecule, pYes2.1-LIP2-V5/His (NS) was also
constructed. In this molecule, the LIP2 open reading frame is extended to include amino acids
encoding the V5 epitope to facilitate detection of the protein in yeast by western blotting. These
constructs are diagrammed in Figure 3-3.

Figure 3-1: pYes2.1 yeast shuttle vector
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It has been observed that expression of heterologous genes in yeast may be limited by
features that are subtly different between organisms, factors such as codon usage or recognition
by processing enzymes. Knowing this, plasmids were constructed with modifications to
compensate for these subtle differences. To optimize lipase secretion, several modifications
were made to the LIP2 gene. The modifications were designed to enhance the features of the
gene that were specific to the Y. lipolytica expression system and tailor them for S. cerevisiae
expression. The modifications involved the KEX2 cleavage site, the signal sequences and the
codon preferences.
Bgl II (493)
Bgl II (336)
Sac I

Pst I (1126)

Age I

Pro region

Pst I
Hpe I

Hind
ORF

Eco RV

Pvu I

LIP2 gene from Yarrowia lipolytica
1304 bp
Figure 3-2: LIP2 / LIP2NS gene
KEX2 endoprotease Yarrowia lipolytica uses the XPR6 gene product to cleave the
proregion and release the mature form of the protein. Pignede et al. found that the removal of
the proregion is not required for release of the mature protein. The presence of the proregion
does not inhibit lipase secretion and activity. The mature protein, however, is less stable. Unlike
Y.lipolytica, S. cerevisiae utilizes the Kex2 endoprotease for prosequence cleavage. To ensure
efficient cleavage in the S. cerevisiae system, the amino acid sequence of the cleavage site of the
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LIP2 gene was optimized to include a serine codon in the P’1 site. The serine codon was added
based upon experiments examining the kinetic and enzymatic preferences of the KEX2 protease
(Rholam et al. 1995). Site directed mutagenesis was used to add serine at position P’1 in the
LIP2 gene. pYes2.1-LIP2 and pYes2.1-LIP2NS were used as templates for extension using
mutagenic primers as described in Materials and Methods. The resulting molecules were
sequenced to ensure that the serine addition was the only mutation introduced. These plasmids
are diagrammed in Figure 3-3.

SERtop
SDM primer

Bgl II (493)

Bgl II (336)
SERbottom
Sac I
SDM primer Pro region

Pst I (1126)

Age I

Hind
ORF

Pst I
Hpe I

Eco RV

Pvu I

LIP2, with Ser added after KEX2 site
1305 bp
Figure 3-3: LIP2Ser / LIP2SerNS gene
Codon optimization. Codon usage has been correlated with expressivity (as measured
by the codon adaptation index) in S. cerevisiae. This link makes codon optimization necessary
in the case of foreign gene placement. The composition of genes is vital to translational
efficiency. Presumably translational efficiency and codon usage are linked because some tRNAs
are more abundant than others (Fuglsang 2004). More highly expressed genes tend to use the
abundant tRNAs thus minimizing the risk of tRNA depletion during translation. Thus, to

34

enhance the expressivity of LIP2, the gene was codon optimized by the Genscript Corporation.
In analyzing the final optimized DNA sequence, the LIP2opt sequence and LIP2Ser sequence
have 72.03% sequence identity (757/1051 nucleotides) (Appendix D). The nucleotide changes
are not in one particular area, but are spread evenly throughout the sequence. The nucleotide
sequence has changed, while the amino acid sequence remained the same. The codon optimized
gene was cloned into pYes2.1, forming pYes2.1-LIP2opt.
CPY signal sequence. Signal peptides govern the entry of almost all proteins to the
secretory pathway. Signal sequences form the N-terminal portion of the amino acid chain and
are cleaved off as the protein is translocated through the membrane (Nielsen 1990).
Carboxypeptidase Y (CPY) contains the native signal sequence to the yeast vacuole in S.
cerevisiae. CPY is a member of the serine carboxypeptidase family and a 61 kD vacuolar
enzyme. It is synthesized on ER bound ribosomes as an active glycosylated precursor
(preproCPY). The CPY signal sequence is removed by signal peptidase, forming proCPY. The
presence of the propeptide is important for the correct folding of CPY and the role that the large
carbohydrate moiety plays on the stability and function of CPY (Takahashi et al. 2001 and Kato
2003). Then, proCPY is transported from the endoplasmic recticulum to the Golgi apparatus,
where it undergoes core glycosylation (unproCPY, if not glycosylated), then to the vacuole. At
or immediately prior to its arrival at the vacuole, proCPY is proteolytically cleavd to its mature
active form (Blachly-Dyson and Stevens 1987). The amino terminal signal sequence (pre
region) is important for efficient translocation, but not absolutely required (Blachly-Dyson and
Stevens 1987). In contrast, the pro region is essential for in vivo and in vitro protein folding and
unfolding and ensuring cooperative structural transitions (Kato et al. 2003).
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In choosing further modifications to the LIP2 gene for potential improvement, changing
the signal sequence from the XPR6 sequence to a native Saccharomyces signal sequence seemed
an obvious choice. Accordingly, the native pre-pro sequences have been replaced by ER
targeting signal derived from S. cerevisiae carboxypeptidase Y (Lip2-CPY). Replacing the
signal sequence was done to increase the likelihood of successful translocation, cleavage, and
secretion of a true lipase. Only the proregion of CPY was cloned into S. cerevisiae because it
has been established that the pre region was not necessary for correct transport of the mature
protein (Pignede et al. 2000). The resulting plasmid is named pYes2.1-LIP2-CPY (Figure 3-4).
All of the modified LIP2 strains are compared in Figure 3-5.

Bgl II (467)
Bgl II (335)
Anneal portion of CPY-LIP2
primer
Stu I
carboxypeptidase Y
signal peptide

Sac I

Age I

ORF

Pst I
Hpa I

Pst I (1100)

Eco RV

LIP2, with carboxypeptidase Y signal sequence
1337 bp
Figure 3-4: Schematic diagram of LIP2 CPY/CPYNS gene construct
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Pvu I

2µ

Pre
LIP2:

URA

Amp

LIP2

Pro

Mature

MKLSTILFTACATLAAALPSSITPSEAAVLQKR-VYTST

LIP2-ser: MKLSTILFTACATLAAALPSSITPSEAAVLQKRSVYTST
LIP2-OPT: MKLSTILFTACATLAAALPSPITPSEAAVLQKRSVYTST
LIP2-CPY:

MKAFTSLLCGLGLSTTLAKTST

Figure 3-5: Properties and genetic modifications to the LIP2 gene. Wild type LIP2 sequence
consists of three regions: pre-sequence (boxed), pro sequence, and mature protein. Cleavage sites
are indicated by arrows, Lysine-Arginine dibasic cleavage site is in blue type. LIP2, wild-type
amino acid sequence; LIP2-ser, LIP2 sequence that has been modified to include an additional
serine residue for optimal cleavage by the S. cerevisiae Kex2 protease (red); LIP2-opt, synthetic
LIP2 sequence optimized for S. cerevisiae codon preferences (bold, underlined); LIP2-CPY,
LIP2 sequence in which the native pre-pro sequences have been replaced by a bona fide ER
targeting signal derived from S. cerevisiae carboxypeptidase Y (underlined).
Lipase Secretion
Halo Assay for Lipase Activity. S. cerevisiae cells containing the pYes 2.1 vector and
respective LIP2 gene variants were grown on agar plates containing the triacylglycerol tributyrin
as the sole carbon source. The function of the agar plate assay was to produce a qualitative sign
of lipolytic activity by the yeast cells. If the yeast cells were secreting a lipase, the tributyrin
would be hydrolyzed, causing the region around the cells to become clear, forming a halo. The
cells were plated in three groups: 1. pYes 2.1-LIP2, LIP2-Ser, LIP2-CPY (Figures 3-6 and 3-7);
2. LIP2, LIP2-Ser, LIP2-opt; 3. LIP2NS, LIP2-SerNS, LIP2-CPYNS (not shown). All plates
included pYes2.1 (empty plasmid vector) as a negative control. Positive controls using
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commercial lipase purchased from Sigma-Aldrich at concentrations of 1 mg/ml, 0.5 mg/ml and
0.1 mg/ml were performed on separate agar plates to prevent interference.

Yeast strain

1

2

3

4

LIP2

LIP2-Ser

LIP2-CPY
Empty plasmid

Figure 3-6. Growth and lipase activity of S. cerevisiae cells on agar containing tributyrin. Cells
growing exponentially in SDextrose at 30° were diluted to 0.25 OD/ml and 10µl of cells were
used to inoculate YNBT plates. The plate assay contains either wild-type yeast cells (empty
plasmid), or yeast cells that have been engineered to secrete lipase enzymes into the growth
media LIP2, LIP2-Ser and LIP2-CPY). The plates contain tributyrin, and the presence of lipase
activity was detected by a “clearing zone” or halo around the colony. Lipase secretion was
detected as a halo after 3 days incubation.
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Yeast strain

1
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3
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LIP2
LIP2-SER
LIP2-CPY

Figure 3-7. Growth and lipase activity of S. cerevisiae cells on agar containing tributyrin over a
period of 72 hours (pYes2.1 LIP2, LIP2 Ser and LIP2 CPY). The growth conditions are as
described in Figure 3-6. The progression of cell growth and lipase secretion on the agar plate
lipase assay. Top (A): 15 hours incubation, middle (B): 24 hours, bottom (C) 48 hours.
The second group of plate assays consisted of cells containing the LIP2 gene, LIP2-Ser
and LIP-opt genes (Figure 3-8). It is significant to note that this plate assay was done using cells
salvaged from the basement. The cells were diluted to lower the possibility of contamination,
plasmid isolation was repeated and the cells were re-transformed into yeast. Rather than spotting
10 µl of culture the cells were serial diluted to concentrations of 100, 50, 10, 5, and 1 OD/ml
then 10 µl those cultures were spotted onto the agar plates. We serial diluted the cultures to
determine the lowest concentration at which lipase production could be detected. The final
group of plate assays contained the NS constructs (LIP2NS, LIP2-SerNS, LIP2-CPYNS). There
is no figure because none of the NS constructs produced a halo.
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Yeast strain
100 OD 50 OD

10 OD

5 OD

1 OD

LIP2
LIP2-opt

LIP2-SER
Figure 3-8. Growth and lipase activity of S. cerevisiae cells on agar containing tributyrin. The
yeast strains growing on the plate are LIP2 (native gene), LIP2-opt (codon optimized) and LIP2Ser (serine added after cleavage site) (empty plasmid not shown). The cells were diluted to 100
OD/ml, 50 OD/ml, 10 OD/ml, 5OD/ml and 1 OD/ml to determine the lowest concentration of
cell culture that can produce and secrete a visible amount of lipase. The OD or OD/ml refers to
the optical density of the culture which is a measure of the number of cells/ml present in a yeast
culture.
The lipase activity of the yeast cells were qualitatively determined daily by visual
assessment and quantitatively by using measurements of the cells and halo regions and annulus
calculations. Using the Multi Gauge software from Fuji Film Life Sciences (Tokyo, Japan), the
diameter of the cells and the halo were defined by lines drawn through the center of the cell and
halo (radii). The software provides the length of the radii. The cell and the halo surrounding it
can be defined as two concentric circles. Once measured, the annulus calculation (Figure 3-9),
provides a numerical value for the region between the two circles. The data gives details on the
amount of lipase produced by observing the size of the hydrolyzed region. Furthermore,
information regarding the rate of lipase production can be gleaned from annulus data collected
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over several days. Generally plate assays were discarded after 4 days because cell death and the
subsequent release of cellular contents may hydrolyze tributyrin and artificially inflate the data.

Aannulus = π (a2 – b2)

Figure 3-9. Annulus. An annulus is defined as the region lying between two concentric circles.
The area of the annulus formed by two circles of radii a and b, with a > b. (Weisstein 2002).
In the first set of plates (LIP2, LIP2-Ser, LIP2-CPY), colonies containing the LIP2 and
LIP2-Ser gene had the largest halos on visual inspection. Using the Student t-test we determined
that there was no significant difference between the halos produced by the LIP2 and LIP2-Ser
colonies (P = 0.126 at 24 hours, 0.14 at 48h and .05 at 72h). Surprisingly, cells containing the
LIP2-CPY gene produced halos that were consistently smaller than the halos from LIP2 and
LIP2-Ser colonies. According to the t-test there is a significant difference between the halos
from LIP2 and LIP2-CPY (P = 2.6 x 10-8 at 24 hours, 1.6 x 10-5 at 48h and 8.9 x 10-8 at 72h) and
LIP2-Ser and LIP2-CPY (P = 3.6 x 10-6 at 24 hours, 8.8 x 10-6 at 48h and 2.6 x 10-8 at 72h).
From these results we concluded that the carboxypeptidase Y signal sequence may not function
well without its pre-region despite reports to the contrary. We also speculated that incomplete

42

cleavage of the proregion from the mature protein may be a factor in poor or decreased action of
the lipase gene. A simpler explanation is that the prepro signal sequence is not compatible with
the LIP2 gene. From this experiment, we chose the yeast cells containing the LIP2-Ser gene for
insertion into the oil inducible vector and further experiments because it promising levels of
lipase secretion (Figure 3-10).
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Figure 3-10. Lipase secretion as measured by annulus size at 15 hours. The annulus was
produced by cell colonies spotted onto agar plate and grown at 30°C. Cells producing a lipase
hydrolyzed the tributyrin in the agar, producing a halo that was measured using the annulus
calculation. Bars denote standard error.
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Average Annulus at 24 hours
90
80

70
60

mm

50
40

30
20

10
0
LIP2

LIP2-Ser

LIP2-CPY

Figure 3-11 Lipase secretion as measured by annulus size at 24 hours. Cells were grown
under the same conditions as described in Figure 3-10
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Average Annulus at 72 hours
300

250

mm

200

150

100

50

0
LIP2

Figure 3-12

LIP2-Ser

LIP2-CPY

Lipase secretion as measured by annulus size at 72 hours.

In the second set of plates (pYes2.1- LIP2, LIP2-Ser, LIP2-opt) there was no significant
difference between the size of the halos produced at 24 hours in 100 OD/ml colonies. At 50
OD/ml there was a significant difference between the LIP2 and LIP2-opt halo size. At 48 hours
there was no significant difference between the sizes of any of the halos at any concentration.
The average annulus size for the second group of plate assays at the 24 hours is shown in Figure
3-11 while average annulus size at 48 hours is shown in Figure 3-12.
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Average Annulus at 24 hours in Serial diluted cultures
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LIP2 LIP2-CPY LIP2-Ser
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Figure 3-13: Average annulus size at 24 hours in serially diluted cultures. The annulus was
produced by cell colonies spotted onto agar plate and grown at 30°C. Cells producing a lipase
hydrolyzed the tributyrin in the agar, producing a halo that was measured using the annulus
calculation. These cells were diluted to higher optical densities to determine at which
concentration cells would cease to produce measurable amounts of lipase. Bars denote standard
error.
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Figure 3-14: Average annulus size at 48 hours in serially diluted cultures. Cultures at 100 OD/ml,
50 OD/ml, 10 OD/ml, and 5 OD/ml are shown.

In the final set of plates that contained colonies of pYes2.1-LIP2NS, LIP2-SerNS, LIP2CPYNS grown on agar containing tributyrin. All open reading frames were built with and
without the stop codon which creates C-terminal V5-peptide fusion, which can be recognized by
anti-V5 antibody. These cells were not thought to be very different from their stop codon
counterparts. The C-terminal fusion was only looked upon as a convenience for western
blotting. Surprisingly, the plate assay for cells constructed without the stop codon produced no
halo (plate not shown).
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To determine the quantitative value of measuring the annulus of lipase producing
colonies we plotted annulus size versus cell number (Figure 3-15). We have speculated that the
size of the annulus directly correlates to the amount of lipase secreted. From the data, annulus
size is proportional to cell number to a point. At 100 OD/ml, the annulus size seems to reach
saturation. The data does lend credence to using the annulus calculation as a quantitative
measure of lipase secretion because lipase secretion is greater at higher cell numbers due to more
active constructs.

Annulus size vs. Concentration
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Figure 3-15: Annulus size vs. cell number.
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50 OD/ml

100 OD/ml

Spectrophotometric Lipase Assay. To quantify the lipase secreted by our yeast cells we tried a
quantative spectrophotometric lipase assay. Despite repeated attempts and multiple
modifications, no activity was detected. In general the spectrophotometric method is the most
common procedure used for lipase assays due to its 10-4 U threshold of detection of lipase
activity (U is the amount of enzyme required to yield 1 µmol product per minute). The least
amount of materials and enzyme are required for the spectrophotometric method (Pinsirodom
and Parkin 2001). Modifications to the assay system included pH adjustments, length of culture
incubation (growth), and reagent and culture volumes (Appendix E).
Expression of a lipase in yeast using a fatty-acid inducible gene promoter
pEX11 vector. To couple the processes of fatty acid uptake into S. cerevisiae cells and
lipase production, open reading frames of lipase constructs showing robust activity were
expressed in yeast cells using the fatty acid-inducible yeast PEX11 gene promoter. The PEX11
gene encodes a protein (Pex11p) that is involved in proliferation of peroxisomes in response to
certain environmental cues (Erdmann and Blobel 1995; Marshall et al.. 1995). The PEX11 gene
is expressed at low basal levels in glucose and induced approximately 100-fold when cells are
shifted to media containing fatty acids as a sole carbon source (Marshall et al 1995). Thus, we
chose to construct plasmids using this promoter creating plasmids pEX11-424-LIP2 Ser, pEX11426-LIP2, LIP2 Ser, LIP2 opt and ∆PstI
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Figure 3-16. Single copy vectors for fatty acid-inducible gene expression in yeast (Dyer et al.
2002).
Analysis of FAME. Dyer et al. found that yeast cells could take up the free fatty acids of
triglycerides from the growth media if a lipase was exogenously added to first breakdown the
triacylglyceride (Dyer et al 2000). Under these conditions, the fatty acid composition of the
yeast mimicked that of the sesame seed oil in the growth media and included linoleic and
linolenic acids which are not normally present in yeast. The fatty acid composition of native S.
cerevisiae cells consists of palmitic, palmitoleic, stearic and oleic acids (Figure 3-18). Yeast
does not possess the enzyme to make linoleic acid and thus lacks this fatty acid. To circumvent
the need to add a lipase to hydrolyze TAG in the growth media, the LIP2 gene and derivatives
were transformed into the S. ceresisiae cells. Once it was confirmed by agar plate assay, that the
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yeast cells containing the LIP2 gene and its derivatives were actively secreting a true lipase, we
repeated the previous experiments. The yeast cells were cultured in linoleic acid or soybean oil
as the sole carbon source. The cellular lipids were harvested, converted to their methyl esters by
transmethylation and analyzed by gas chromatography.
Gas chromatography revealed several trends in the lipid profiles of cells. Both wild type
and pEX11-LIP2Ser cells cultivated in the presence of free linoleic acid contained over 80% of
their fatty acids as linoleic acid (Figure 3-17 and 18), implying that the cells can take up and
store this molecule. Wild type cells cultivated in soybean oil (Figure 3-20), by contrast,
contained 45% of their fatty acids as oleic acid and, only 13% as linoleic acid. The high
percentage of oleic acid is more consistent with the profile of wild type cells (Figure 3-16),
because yeast is unable to take up soybean oil as a triglyceride and cannot hydrolyze it
extracellularly into component free fatty acids. Incubation of yeast cells containing the LIP2Ser
gene in the presence of soybean oil (Figrue 3-21) resulted in an uptake of linoleic acid, which is
comparable to the amounts found in soybean oil (54%) (Figure 3-19). Most notably, cells
containing the LIP2Ser gene had 50% of their fatty acids as linoleic acid and other fatty acids in
similar percentages to soybean oil. From this data we conclude that the modified LIP2 strain,
LIP2Ser in an oil inducible vector, is able to secrete a lipase into the growth media that
hydrolyzes triacylglycerols. Once hydrolyzed, the free fatty acid component parts of the
triacylglycerol are taken up by the yeast cell and stored.
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Figure 3-17 Fatty acid composition of wild type yeast cells (pEX11-424). Cells were grown
under minimal media starvation then fatty acids were harvested.
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Figure 3-18 Fatty acid composition of wild type yeast cells (pEX11-424) grown in the
presence of the free fatty acid linoleic acid. Cells were grown under minimal media
starvation and in the presence of linoleic acid for 24 hours. After that period the cells were
boosted with yeast peptone. The cells were then harvested and fatty acids were extracted.
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Figure 3-19 Fatty acid composition of pEX11-424 LIP2Ser cells grown in the presence of
the free fatty acid linoleic acid.
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Figure 3-20.

Fatty acid composition of Hain Soybean Oil.

55

Li
no
le
na
te

ea
te
Li
no
l

at
e
O
le

St
ea
ra
te

ito
le
at
e
Pa
lm

Pa
lm

0

ita
te

10

pEX11-424+soybean oil
50

% FAME

40
30
20

Li
no
le
na
te

te
Li
no
lea

e
Ol
ea
t

te
ar
a
St
e

ito
le
at
e
Pa
lm

Pa
lm

0

ita
te

10

Figure 3-21. Fatty acid composition of wild type yeast containing the empty vector
pEX11-424, grown in Soybean oil.
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Fatty acid composition of pEX11-424 LIP2Ser, grown in the presence of soybean
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Discussion
Our laboratory is interested in development of microbial systems that are capable of
converting low cost lipids into value added products. It has been demonstrated that
Saccharomyces cerevisiae (bread yeast) is able to acquire free fatty acids from the growth media
and that a portion of these lipids can be converted into new lipid products by transgenically
expressed enzymes (Dyer et al. 2001). Yeast cells cannot, however, acquire complex lipids such
as triacylglycerols from the growth media unless a nonspecific lipase is included to first release
the fatty acid components. Economically, it is far more efficient to engineer the yeast cells to
secrete this enzyme as needed to complete all of the necessary metabolic steps. In the work
described above, we have engineered S. cerevisiae for secretion of lipase enzymes. In doing this
we hope to use yeast as a platform for lipid metabolic engineering. The power and flexibility of
yeast genetics/molecular biology can be used to develop methods for biotechnological
conversion of low-cost oils into value-added products. The experimental strategy is to fuse a
fatty acid inducible gene promoter to a secreted lipase enzyme sequence. The yeast PEX11
promoter is expressed at low, basal levels in all media and is strongly upregulated in the presence
of free fatty acids. Expression of the Yarrowia lipolytica LIP2 gene behind the PEX11 promoter
will allow basal levels of LIP2 expression in dextrose media, resulting in secretion of a small
amount of lipase enzyme into the growth medium. Addition of TAGs will result in breakdown
by the LIP2 enzyme, and fatty acid components will be taken up into yeast cells, which will
upregulate expression of the LIP2 gene by the PEX11 promoter. Once the TAGs are broken
down, fatty acid content of the media will decrease, and LIP2 expression will be downregulated.
Following initial observations and taking into account the features of the yeast secretory
pathway and other inherent features of the cell, modifications were made to the signal sequence,
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cleavage sites, promoter regions and codon usage of the LIP2 gene. Each modification was
made individually and tailored to different phases of the secretory pathway. Through
experimentation we found that inserting the lipase gene into S. cerevisiae secretes a nonspecific
lipase into the growth medium. Early examination of the halo assay led us to believe that
modifying the LIP2 gene by inserting a serine codon after the KEX2 protease cleavage site
appears to have increased the amount of lipase secreted.
The P’1 position, which is the amino acid residue immediately following the clevage site,
of the KEX2 gene has been found to exhibit preference for particular features of amino acids
rather than strict specificity for a given amino acid residue. Several frequency calculations on the
occurrence of particular residues at each position, P6 – P’4, illustrated several features that may
increase the likelihood of cleavage at dibasic sites (Rholam et al. 1995). In analyzing the results
for the P’1 position, resulting in cleavage, it was found that a cleavage favorable P’1 residue
would be hydrophilic, a β-turn former, polar and tiny. From the classification provided, only one
amino acid – serine – fit all of the criteria. Further analysis of ratios of amino acids at processing
sites (cleaved: uncleaved) revealed another short list of amino acids (Phe, Tyr, His, Ala, Ser,
Asn, Asp, Glu) produceing a high frequency of cleavage at the P’1 site. The last test for varying
amino acids at the P’1 position involved an examination of the kinetic parameters of Kex2
endoprotease cleavage. The Km and Vmax of several peptide substrates were collected from
velocity measurements and plotted versus various substrate concentrations. A ratio of Vmax to
Km provides data on the efficiency of the enzyme. Only 5 amino acids produced significant
frequencies of cleavage, Ala, Asp, His, Ser, and Gly. Based on these results serine proved to be
the best substrates for hydrolysis by the Kex2 endoprotease at the P’1 position (Rholam et al.
1995). In choosing an amino acid residue to improve the XPR6 endoprotease signal on the LIP2
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gene, serine was the best choice because it provides the properties most likely to cause cleavage
at the P’1 site. It is pertinent to note that in Y. lipolytica glutamine occupies the P’1 position
while the position is held by glutamic acid in S. cerevisiae (Fuller et al. 1999, Enderlin and
Ogrydziak 1994). Glutamic acid, glutamine and serine have some features in common which
provided further assurance regarding use of serine in the P’1 position. All three amino acids have
polar side chains. Glutamine and serine are both have neutral side chains (Voet et al. 1999).
Modifying the LIP2 gene by codon optimization and insertion of the carboxypeptidase Y
signal sequence has proved less successful. Halo assays show that these two constructs secrete
less lipase than cells containing the LIP2 and LIP2-Ser constructs. CPY is a vacuolar protein
and is not normally secreted from the cell unless it is overexpressed (Westphal et al 1996).
Lipase may be produced as a result of the LIP2-CPY gene, but it my have been targeted to the
vacuole, or the protein may remain in the endoplasmic reticulum.
Codon usage has been linked to gene expressivity (measured using the codon adaptation
index). The composition of genes is critical for translational efficiency. Expressivity and codon
usage are linked because some tRNAs are more abundant and the use of ‘rare’ tRNAs can limit
translation rate and efficiency. Several studies have revealed that highly expressed genes use the
more abundant tRNAs, which avoids the possibility of tRNA depletion during translation.
Placement of foreign genes into cells and the resulting expressivity was originally studied in
E.coli. Foreign genes introduced in E.coli having genes corresponding to rare codons, produced
low yield despite high amounts of transcripts. When these codons of the introduced gene were
point mutated to more commonly used codons, protein yield was improved in some cases.
Similar results have been found in S.cerevisiae. These findings lend credence to the approach of
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using codon optimization of foreign genes to ensure expressivity (Fuglsang 2004). In this study,
the LIP2 gene was optimized by GenScript (http://www.genscript.com).
The LIP2-opt gene performed well below expectations. The decrease in lipase secretion
could be due to several factors: inadvertent creation of an unstable RNA, protein aggregation
caused by over expression, or protein folding problems. Another reason could be the loss of
translational pausing. Non-optimal codons are defined by low usage and low abundance of
corresponding tRNA and have an established role in translational pausing to allow the correct
folding of proteins (Zalucki et al 2007). While this is a bacterial example, it is valid to note that
the LIP2 lipase may not be produced because it is proceeding through translation too quickly
either producing incorrectly folded lipases that are not secreted, or secreted lipase that has no
enzymatic activity. Monitoring protein expression by northern blotting or RT-PCR would
elucidate this situation.
The NS constructs, constructs with their stop codon removed and ORF fused to a V5/His
reporter, were initially viewed as the same as their counterparts containing stop codons. These
constructs were created mainly for use with Western blotting for ease of detection. The halo
assay revealed that there was no lipase secreted or an inactive lipase was secreted from all of the
NS constructs. Yu et al. (2007) in working with LIP2 and Fickers et al. (2005) working with
LIP7 and LIP8 report loss of enzymatic activity and instability in proteins containing C-terminal
His tags. The problem with our no stop constructs may lie in the addition of the C-terminal tags.
It may be that there is a conserved region in the C-terminal region or that the protein is too
rapidly degraded to be detected by the agar plate assay. Furthermore, there is a cysteine residue
3 amino acids from the end of the LIP2 gene. In RAS proteins the cysteine residues are 4 from
the end and act as sites for post-translational modification. In our case, the NS gene constructs
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may lack post translational modification due to the presence of the His tag. Rather than tag the
C-terminal end of the protein, an N-terminal tag attached to the mature protein by site directed
mutagenesis may prove successful. Song et al. (2006) reported that a 6-His tag at the N-terminus
had little effect on the activity or stability of recombinant Lip7 and Lip8 lipases.
The annulus calculation has been helpful in this case, but the results are sharply limited
by the human eye and the resolution of the monitor or printer displaying the plate image.
Distortions in the plate image can easily be confused for halos. Furthermore cell death and lysis
could be contributing to the resultant halo more than previously thought. While the assay is
limited, the graph of annulus size in relation to cell number showed that lipase secretion is
proportional to cell number, leading us to believe that using the annulus calculation is a good
indicator of the quantity of lipase secreted. A sensitive and quantitative lipase assay would
provide more definitive data regarding lipase secretion by cells containing each gene construct.
We speculate that the spectrophotometric lipase assay did not work because there was not
enough enzyme for detection or our lipase did not cleave the substrate used in the assay. While
the assay was tested using a commercial lipase, the yeast enzyme may be more selective in
cleaving substrates.
The results from gas chromatography are reliable. The results confirm that the lipase
secreted from cells containing the LIP2-Ser gene confers uptake of triacylglycerols into yeast
cells. All of the cells and experiments were in good working order at the time of culturing,
harvesting and transmethylation. More gas chromatography would confirm the current results.
While the halo assay confirms the secretion of a lipase and gas chromatography confirms that
triacylglycerols are broken down by the lipase and taken up by the cells, there are further
question and experiments needed.
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Northern blotting would provide data regarding the activity of the LIP2 gene when a
lipid is added to the growth media. Specifically, Northern blotting would let us know if the LIP2
gene is temporarily induced when lipid is added to the growth medium and is this induction
dependent upon the presence of the LIP2 gene. The experimental setup would use the
endogenous PEX11 gene as a control. The probe should be to the PEX11 open reading frame
(endogenous gene) rather than the LIP2 gene to garner information on the behavior of the PEX11
promoter in the presence of TAG, but absence of lipase. Actin could be used as a control for the
Northern blot. In comparison the wild type + pEX11-LIP2-SER, blotting for PEX11 and LIP2SER would provide data on the induction of the LIP2 gene in the presence of TAG and the
secreted lipase.
Western blotting would provide information on the lipase protein levels detectable in the
growth medium. For western blotting, the cells are cultivated under normal conditions;
supernatant is collected at specific time points, concentrated and analyzed on protein gel
(Coomassie stain). Some of these experiments were performed as a part of this study, but did not
produce useable results. In addition to confirming the current results, efforts to engineer S.
cerevisiae to secrete large amounts of lipase for breakdown of triglycerides and incorporation of
fatty acid components should be revived. Such strains of S. cerevisiae have previously been
described (Okkels 1996), as well as other methods to produce an overproduction of a lipase.
These efforts may permit the industrial- scale utilization of S. cerevisiae for bioconversion of
low-cost starting materials into value-added lipid products.
We attempted to overproduce the LIP2 lipase by creating a system, based on the Leu2
system, but met with little success. Once constructed, mmPEX 11-426∆PstI was transformed
into yeast with very low transformation efficiency. J.S. Okkels (1996) found that deleting the
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URA3 promoter region from the pYes2.0 plasmid increases the expression level of a fungal
lipase several fold in S. cerevisiae. More specifically, the deletion originates 17 bp from the
URA3 gene initiation sequence. The deletion includes the RNA polymerase initiation sequences,
the TATA box, and the 3’ overhang of the PstI site. Overall lipase expression for URA3
deletion plasmids is higher than expression in plasmids containing the promoter region. After
removing the PstI sites in pYes2 to accommodate the insertion of the lipase gene from Humicola
languinosa, it was found that plasmids giving the highest number of colonies were lacking the
URA3 promoter. In removing the 484 bp PstI fragment, the URA3 promoter region and part of
the 2µm fragment was removed as well (Okkels et al 1996).
In a practical setting, the URA3 promoter is easily removed from pYes vectors by
removing the two PstI sites that flank the entire promoter. Okkels 1996 contends that the
increase in expression is a result of poor expression of the URA3 selection marker resulting from
the deletion. As a result of this poor expression there is a higher copy number per cell of the
plasmid. Higher copy number can increase the transcript level per cell of the plasmid and
subsequently the cellular expression level of the gene.
The primary goal of this project is to convert S. cerevisiae into a facultative oleaginous microbe
through the use of yeast as a platform for lipid metabolic engineering. Complete conversion of
S. cerevisiae requires four novel functions to occur within the yeast cell: (1)sense TAGs in the
growth media, (2) upregulate expression of a lipase gene, (3) secrete a nonspecific lipase, and (4)
down regulate gene expression once the TAGs have been utilized. These four functions establish
a self-regulating positive feedback loop of gene regulation. The synthesis portion of
metabolically engineering yeast involves the introduction of a strong promoter, for gene
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regulation, selection of a non-specific lipase for TAG breakdown, and production of a TAG
enriched growth media, to activate the promoter.
Establishing this closed system requires several genetic modifications. First we fused a
fatty acid inducible gene promoter to a secreted lipase enzyme sequence. The yeast PEX11
promoter is expressed at low, basal levels in all media and is strongly up regulated in the
presence of free fatty acids. The PEX11 promoter demonstrated 100-fold induction when cells
were grown in oleic acid as the sole carbon source (Marshall et al. 1995, Kal et al. 1999).
Expression of the Yarrowia lipolytica LIP2 gene behind the PEX11 promoter will allow basal
levels of LIP2 expression in dextrose media, resulting in secretion of a small amount of lipase
enzyme into the growth medium. The lipase produced as a result of the LIP2 gene will cleave
TAGs in the growth media, and the fatty acid components will be taken up into yeast cells,
which will upregulate expression of the LIP2 gene by the pEX11 promoter. Once the TAGs are
cleaved, fatty acid content will decrease, and LIP2 expression will be downregulated.
Once these modifications are completed, these objectives can merge with other areas of
this project. Another phase in the project is to co-express multiple lipid modifying enzymes to
convert the exogenously acquired oils tung like drying oils. Currently there are plasmid-borne
expression systems that will allow co-expression of up to 4 different genes in yeast cells (Dyer et
al. 2002). There are also additional options such as yeast artificial chromosomes available for
co-expressing many more genes if necessary. While the primary goal is to use this oleaginous
yeast expression system for analysis and reconstitution of the tung oil biosynthetic pathway, the
S. cerevisiae system allows any lipid-modifying enzyme to be used in our expression system.
Therefore, successful development of an efficient bioconversion system could serve as a
platform for conversion of low cost lipids into a variety of value added products.
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Appendix A: Sequence of Oligonucleotide Primers

Name

Sequence

Purpose

LIP2 Forward

5’GCCACCATGAAGCTTTCCACCAT
CCTTTTC 3’

To extract the LIP2 gene from Yarrowia lipolytica

LIP2 Reverse

5’CCTTAGATACCACAGACACCCTCG
GTGAC3’

LIP2RevNoStop

5’GATACCACAGACACCCTCGGTGAC
GAAGT3’

GAL1Forward (Invitrogen) 5’ AATATACCTCTATACTTTAACGTC3’
V5Reverse (Invitrogen)

5’ACCGAGGAGAGGGTTAGGGAT3’

LIP2SeqForward

5’TCCCGGCACTAAGATCTTCAAGCCC
TTC3’

LIP2SeqReverse

5’ACTGCTGGTAACCGTCCCAGAGCAC3’

SERTop

5’GCCGCAGTTCTCCAGAAGCGATC
TGTGTACACCTCTACCGAGACC 3’

SERBottom

5’GGTCTCGGTAGAGGTGTACACAG
ATCGCTTCTGGAGAACTGCGGC 3’
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To sequence pYes2.1 based plasmids

To sequence the LIP2 regions of plasmid constructs

To improve the Kex2 cleavage site a serine
codon is being inserted into the LIP2 gene

CPY-Lip2Fusion

5’CCATGAAAGCATTCACCAGTTTAC
TATGTGGACTAGGCCTGTCCACTAC
ACTCGCTAAGGTGTACACCTCTACC
GAGACCTCTCA 3’

To replace the prepro sequence of Lip2 with the
carboxypeptidase Y signal sequence

PEXLip2Forward

5’CAGAGAATTCGCCACCATGAAGCT
TTCC ACCATCCTTTTC3’

To add an EcoRI restriction site to the beginning of
the LIP2 gene for insertion into the pEX11 vector

PEXLip2Reverse

5’ACTTCCCGGGCTCTTAGATACCACA
GAC ACCCTCGGTGAC3’

To add an SmaI restriction site to the end of
the LIP2 gene for insertion into the pEX11 vector
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Appendix B: Plasmid Constructs
Name

Functional Characteristics

pYes2.1

High copy (2 micron), URA, GAL promoter, CYC terminator

pYES2.1 LIP2
pYES2.1 LIP2NS

Native LIP2 lipase from Y. lipolytica

pYES2.1 LIP2 opt

Native LIP2 lipase, codon optimized

pYES2.1 LIP2-Ser
pYES2.1 LIP2-SerNS

LIP2 with improved Kex2 site

pYES2.1 LIP2-CPY
pYES2.1 LIP2-CPY (no stop)

LIP2 with a new signal peptide

pEX11

Oil inducible vector, high copy (2 micron), PEX11 promoter and
terminator

pEX11-424, pEX11-426

TRP1 selectable marker, URA3 selectable marker

pEX 11-426 LIP2

Native LIP2 lipase from Y. lipolytica

PEX 11-426 LIP2-Ser

LIP2 with improved Kex2 site in oil inducible vector

PEX 11-426 LIP2-opt

Native LIP2 lipase, codon optimized

PEX11-426∆PstI

Ultra high copy (Okkels 1996)

NS = No Stop. Indicates V5/His (see Materials and Methods)
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Appendix C: Solutions
10x-Ura
For 250 ml (final volume), dissolve 5 g SCM-Ura supplement to sterile water. Cover beaker
with foil to protect from light. Stir for at least 1 hour. Filter sterilize. Wrap bottle in foil to
protect from light. Store at 4°C.
10x Yeast Peptone (YP)
10% yeast extract, 20% Bacto peptone
For 100 ml, combine 10 g yeast extract and 20 g Bacto peptone in 30 ml sterile water. Stir until
dissolved. Add sterile water to 100 ml final volume. Autoclave and store with lid closed tightly
until used. Solution contaminates easily.
50X TAE
For 1L, combine 242 g Tris base, 57.1 ml glacial acetic acid and 100 ml 0.5 EDTA (pH 8.0) in
500 ml sterile water. Add water to a final volume of 1L. Store at room temperature and dilute to
1X for use. 50X TAE may also be purchased commercially and diluted for use.
1000X Vitamins
For 1L, add the following: 2 mg biotin, 400 mg calcium pantothenate, 2 mg folic acid, 2000 mg
inositol, 400 mg niacin, 200 mg p-amino benzoic acid, 400 mg pyridoxine-HCl, 200 mg
riboflavin (does not dissolve completely), and 400 mg thiamine. Stir and store in 50 ml aliquots
at 4°C.
1000X Trace Minerals
For 1 L combine the following in 800 ml sterile water: 50 mg boric acid (H3BO4), 4 mg copper
sulfate (CuSO4) (or 6.25 mg copper sulfate pentahydrate, CuSO4 ⋅ 5H2O), 10 mg potassium
iodide (KI), 20 mg iron (III) sulfate (FeCl3 ⋅ 6 H2O), 40 mg manganese sulfate tetrahydrate
(MnSO4 ⋅ 4 H2O) (or 30 mg manganese sulfate, MnSO4 ⋅ H2O), 40 mg zinc sulfate heptahydrate
(ZnSO4 ⋅ 7 H2O) and ammonium molybdate tetra hydrate((NH4)6Mo7O24 ⋅ 4 H2O). Stir until
dissolved, autoclave and store at 4°C.
Ampicillian Stock Solution (100 mg/ml)
For 5ml, dissolve 0.5 g ampicillin sodium salt in 5 ml sterile water. Vortex to dissolve and filter
sterilize. Store in 1ml aliquots at -20°C.
Bacterial transformation Buffer (colony method)
For 50 ml, combine 5 ml 1M KCl (final concentration 100mM), 2.25 ml 1M MaCl2 (45mM), 0.5
ml 1M CaCl2 (10mM), 0.0401g HACoCl3 (3mM) and 0.0980g MES (potassium methylethane
sulfonate) (10mM) in 50 ml sterile water. Adjust to pH 6.2. Store at 4°C. Shake before use to
resuspend the salts.
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DEPC treated water (Ambion)
For 1 L, add 1 ml diethylpyrocarbonate (DEPC) to double-distilled, deionized H2O (final
concentration 0.1%). Stir well. Incubate 12 - 24 at 37°C. Autoclave for at least 45 minutes. The
scent of DEPC should be either not detectable or only very slightly detectable.
Holland Minimal Yeast Media (HMY)
For 1 L add salts in this order to 600 ml sterile water:
(NH4)2SO4
2.5g
.
0.2g
MgSO4 7 H2O
NaH2PO4 . H2O
3.0g
K2HPO H2O
0.7g
Stir until all salts are dissolved. Adjust the pH to 6.0 with H2SO4 or 1M NaOH. Add 10 ml trace
minerals. Mix trace minerals well prior to use. Add 0.5g yeast extract. Add sterile water to final
volume of 900ml. Filter sterilize or transfer to media bottle, autoclave and cool. Add sterile
carbon source and store at 4°C until ready to use.
Lipase stock solution (Sigma) (1 mg/ml)
Add 0.001 g lipase powder to 1 ml deionized, distilled water. Dilute stock solution to 0.5 mg/ml
and 0.1 mg/ml.
Luria Bertani (LB) liquid media
For 300 ml, dissolve 7.5 g LB in 200 ml sterile water. Stir until dissolved. Add sterile water to
final volume of 300ml. Autoclave and store at room temperature.
LB-Ampicillin (LB-Amp) plates
For agar plates, dissolve 7.5 g LB in 200 ml sterile water. Stir until dissolved. Add
sterile water to final volume of 300ml. Add 4.5 g bactoagar and stir until dissolved.
Autoclave. Cool solution to 55°C and add 30 µl ampicillin stock solution. Pour 25 ml
per petri plate. Cool until agar hardens, store plates at 4°C.
p-Nitrophenyl laurate substrate solution, 420 µM
Place 0.0135 g p-nitrophenyl laurate (molecular weight 321.4), 0.017 g sodium dodecyl
sulfate (SDS), and 1.00 g Triton X-100 into a 100 ml volumetric flask and bring to volume with
water. Heat the mixture in a water bath at 65° C for 15 minutes, mix well, and let the solution
cool to ambient temperature prior to use. Store up to 3 days at 4°C. Reheat if the solution
becomes turbid.
p-Nitrophenol standard solution, 0.5 mM
Place 0.0869 g p-nitrophenol (molecular weight 139.1) in a 25 ml volumetric flask and
bring to volume with 0.1 M Tris⋅Cl, pH 8.2. Store up to one month in a tightly sealed vessel at
room temperature. Dilute 1 volume with 49 volumes of 0.1 M Tris⋅Cl buffer for a final 0.5 mM
p-nitrophenol standard solution
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SOC liquid media
For 1000 ml (final volume), combine 2g tryptone, 0.5 g yeast extract, 250 µl 1M KCl, 1 ml 1M
MgCl2, 1 ml 1M MgSO4, and 0.36 g glucose in 600 ml sterile water. Adjust to pH 7.5 with
NaOH and bring solution to final volume. Filter sterilize.
SOB agar plates
For 250 ml, combine 5g tryptone, 1.25 g yeast extract, 625 µl 1M KCl, 2.5 ml 1M MgCl2 and 2.5
ml MgSO4. Adjust solution to pH 7.5 with NaOH and add sterile water to final volume. Add
3.75 g agar to solution. Autoclave. Cool media to 55°C and pour approximately 25 ml per Petri
plate. Allow plates to cool to room temperature. Store at 4°C.
1M Sorbitol
For 50 ml, combine 25 ml 2M Sorbitol and 25 ml sterile water in a graduated cylinder. Cover
graduated cylinder with parafilm and mix by inversion.
1M Sorbitol, 20 mM KPi pH 7.5
For 50 ml, combine 25 ml 2M Sorbitol and 2 ml 0.5M KPi, pH 7.5. Add sterile water to reach
final volume. Cover graduated cylinder with parafilm and mix by inversion.
Synthetic dextrose (SD) – 10X
2% dextose, 0.67% YNB,
For 500 ml, dissolve 10g dextrose and 3.35 g yeast nitrogen base (YNB) in 450 ml sterile water
(final volume). Filter sterilize and store at 4°C.
Agar plates: For 300 ml, dissolve 6 g dextrose and 2.01 g YNB in 270 ml sterile water
(final volume). Add 6 g agar and dissolve. Autoclave. Cool to 55°C and add 30 ml of
10-Ura. Pour approximately 25 ml per plate.
Synthetic galactose (SGal) – 10X
2% galactose, 0.67% YNB
For 500 ml (final volume), dissolve 10g galactose and 3.35 g yeast nitrogen base (YNB) in 450
ml sterile water.
Synthetic glycerol dextrose (SGd)
3% glycerol, 0.1% dextrose, 0.67% YNB
For 500 ml, combine 15 ml glycerol, 0.5 g dextrose, and 3.36 g YNB to 450 ml (final volume)
sterile water. Filter sterilize
TES solution
10 mM Tris-Cl, pH 7.5
10 mM EDTA (0.5 M)
0.5 % SDS (stock is 10%)
Can be stored indefinitely at room temperature
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TES solution
50 x sample buffer
980µL sample buffer
20µL β-mercaptoethanol
0.1 M Tris⋅Cl pH 8.2
For 500 ml dissolve, 6.055 g Tris base in 300 ml deionized, distilled water. Bring
solution to desired pH with concentrated hydrochloric acid (HClaq). Add water to 500 ml and
store at room temperature.
Variations:
0.5 M Tris⋅Cl, pH 6.8, (Okkels 1996)
0.1 M Tris⋅Cl, pH 7.2 (V. Newman, personal communication 2003)
0.1 M Tris-SO4 pH 9.2, 10 mM DTT
For 50 ml, combine 5 mL1 M Tris SO4, pH 9.2 and 0.08g DTT in 30 ml sterile water. Add
sterile water to a final volume of 50 ml. Cover graduated cylinder with parafilm and mix by
inversion.
Yeast Peptone Dextrose (YPD)
(1% yeast extract, 2% peptone, 2% dextrose) 2% agar for plates
For 300 ml, dissolve 15g YPD Broth sterile water. Stir until dissolved. Add 6 g agar for plates.
Autoclave.
Zymolyase 20T
2 ug/OD, and volume of 10ug/uL Zymolyase stock needed to give desired amount of
enzyme/sample.) Total OD (2ug/OD)=ug Zym.(1ul/10ug)=ul Zym. Soln.
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Appendix D: GenScript Report

Codon Optimization Result
( confidential )
Organism: Saccharomyces cerevisiae ;
Gene Name: Gene_opt
Sequence Type: aa
Optimization Region: 13 - 1020
GC Range: 30 - 70
Addition 5' Sequence: GAATTCGCCACC
Addition 3' Sequence: AGATCT
Cut Offs:
Secondary Structure Stack Cutoff: 35
Repeat Cutoff: 21
Relative Frequence Cutoff: 50
5' Splice Score Cutoff: 85
Genetic Code: 1
RE Sites and CIS Pattern:
EcoRI(GAATTC),BglII(AGATCT),splice(GGTAAG),splice(GGTGAT),polya(AATAAA),polya(AAAAAA)
,destabilizing(ATTTA),polyt(TTTTTT),polya(AAAAAAA)
RE Check Sites: SmaI(CCCGGG),EcoRV(GATATC)
RE Keep Sites:
Protein Sequence:
MKLSTILFTACATLAAALPSPITPSEAAVLQKRSVYTSTETSHIDQESYNFFEKYARLAN
IGYCVGPGTKIFKPFNCGLQCAHFPNVELIEEFHDPRLIFDVSGYLAVDHASKQIYLVIR
GTHSLEDVITDIRIMQAPLTNFDLAANISSTATCDDCLVHNGFIQSYNNTYNQIGPKLDS
VIEQYPDYQIAVTGHSLGGAAALLFGINLKVNGHDPLVVTLGQPIVGNAGFANWVDKLFF
GQENPDVSKVSKDRKLYRITHRGDIVPQVPFWDGYQHCSGEVFIDWPLIHPPLSNVVMCQ
GQSNKQCSAGNTLLQQVNVIGNHLQYFVTEGVCGI*
Protein Alignment (Optimized Region):
Optimized
Original

1 MKLSTILFTACATLAAALPSPITPSEAAVLQKRSVYTSTETSHIDQESYNFFEKYARLAN
1 MKLSTILFTACATLAAALPSPITPSEAAVLQKRSVYTSTETSHIDQESYNFFEKYARLAN

Optimized
Original

61 IGYCVGPGTKIFKPFNCGLQCAHFPNVELIEEFHDPRLIFDVSGYLAVDHASKQIYLVIR
61 IGYCVGPGTKIFKPFNCGLQCAHFPNVELIEEFHDPRLIFDVSGYLAVDHASKQIYLVIR

Optimized
Original

121 GTHSLEDVITDIRIMQAPLTNFDLAANISSTATCDDCLVHNGFIQSYNNTYNQIGPKLDS
121 GTHSLEDVITDIRIMQAPLTNFDLAANISSTATCDDCLVHNGFIQSYNNTYNQIGPKLDS

Optimized
Original

181 VIEQYPDYQIAVTGHSLGGAAALLFGINLKVNGHDPLVVTLGQPIVGNAGFANWVDKLFF
181 VIEQYPDYQIAVTGHSLGGAAALLFGINLKVNGHDPLVVTLGQPIVGNAGFANWVDKLFF

Optimized
Original

241 GQENPDVSKVSKDRKLYRITHRGDIVPQVPFWDGYQHCSGEVFIDWPLIHPPLSNVVMCQ
241 GQENPDVSKVSKDRKLYRITHRGDIVPQVPFWDGYQHCSGEVFIDWPLIHPPLSNVVMCQ

Optimized
Original

301 GQSNKQCSAGNTLLQQVNVIGNHLQYFVTEGVCGI*
301 GQSNKQCSAGNTLLQQVNVIGNHLQYFVTEGVCGI*

Optimized Sequence: Length: 1026, GC%:37.33, Minimum Free Energy:-247.30
GAATTCGCCACCATGAAATTGTCTACTATTTTATTCACAGCTTGCGCTACCTTGGCTGCT
GCATTACCATCCCCAATCACTCCTTCTGAAGCAGCCGTTTTGCAAAAGAGAAGTGTCTAC
ACTTCTACTGAAACTTCACATATTGACCAAGAATCTTATAATTTCTTTGAAAAATACGCC
AGATTAGCAAATATCGGTTATTGTGTCGGTCCTGGTACCAAGATTTTTAAACCATTCAAC
TGTGGTTTACAATGTGCTCATTTTCCAAATGTAGAATTAATAGAAGAATTTCATGATCCT
AGATTGATTTTCGATGTATCAGGTTACTTAGCAGTTGACCATGCTTCTAAACAAATATAC
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TTAGTCATCAGAGGTACACACTCCTTAGAAGATGTTATAACAGACATCAGAATTATGCAA
GCCCCTTTAACCAATTTTGACTTAGCTGCTAACATTTCCTCTACAGCTACATGTGACGAT
TGTTTGGTCCACAACGGTTTTATACAAAGTTACAACAACACTTATAACCAAATTGGTCCT
AAATTGGATTCAGTTATCGAACAATATCCAGATTACCAAATTGCTGTCACTGGTCATTCA
TTAGGTGGTGCTGCAGCCTTATTGTTCGGTATAAATTTGAAAGTAAACGGTCATGATCCT
TTAGTTGTTACATTAGGTCAACCAATTGTTGGTAATGCAGGTTTCGCCAACTGGGTCGAT
AAGTTATTTTTCGGTCAAGAAAACCCTGATGTATCCAAGGTATCCAAAGACAGAAAGTTG
TATAGAATTACTCATAGAGGTGACATAGTTCCACAAGTTCCATTTTGGGATGGTTACCAA
CATTGTAGTGGTGAAGTTTTTATCGACTGGCCATTGATTCATCCACCATTGTCTAATGTT
GTCATGTGTCAAGGTCAATCCAATAAGCAATGCTCTGCAGGTAACACTTTATTGCAACAA
GTAAATGTAATCGGTAACCACTTGCAATATTTTGTAACTGAAGGTGTTTGCGGTATCTAA
AGATCT
Restriction Enzymes:
Fitering Enzymes and CIS Pattern:
EcoRI(GAATTC): 1 (1 - GAATTC)
BglII(AGATCT): 1 (1021 - AGATCT)
splice(GGTAAG): 0
splice(GGTGAT): 0
polya(AATAAA): 0
polya(AAAAAA): 0
destabilizing(ATTTA): 0
polyt(TTTTTT): 0
polya(AAAAAAA): 0
Checking Enzymes:
SmaI(CCCGGG): 0
EcoRV(GATATC): 0
Keeping Enzymes:

After Optimization
Codon Frequency Table Used:
TTT
TTC
TTA
TTG

26.1(165543)
18.4(116276)
26.2(165644)
27.1(171648)

TCT 23.4(148304)
TCC 14.2( 90037)
TCA 18.7(118123)
TCG 8.6( 54354)

TAT 18.8(118913)
TAC 14.8( 93431)
TAA 1.0( 6581)
TAG 0.5( 3226)

TGT 8.0( 50767)
TGC 4.8( 30093)
TGA 0.7( 4222)
TGG 10.4( 65681)

CTT 12.2( 77527)
CTC 5.5( 34552)
CTA 13.4( 84648)

CCT 13.5( 85758)
CCC 6.8( 43129)
CCA 18.2(115045)

CAT 13.7( 86674)
CAC 7.8( 49136)
CAA 27.3(173012)

CGT
CGC
CGA

81

6.5( 40930)
2.6( 16463)
3.0( 19067)

CTG 10.5( 66471)

CCG

ATT
ATC
ATA
ATG

30.1(190652)
17.1(108276)
17.8(112751)
20.9(132601)

GTT
GTC
GTA
GTG

22.0(139064)
11.7( 73837)
11.8( 74832)
10.8( 68181)

5.3( 33393)

CAG 12.2( 77168)

CGG

ACT 20.2(127988)
ACC 12.6( 79840)
ACA 17.7(112317)
ACG 8.0( 50519)

AAT
AAC
AAA
AAG

35.8(226818)
24.9(157427)
42.0(265942)
30.9(195431)

AGT 14.2( 89887)
AGC 9.7( 61558)
AGA 21.3(134653)
AGG 9.3( 58663)

GCT 21.1(133660)
GCC 12.6( 79826)
GCA 16.2(102601)
GCG 6.2( 39179)

GAT
GAC
GAA
GAG

37.7(238643)
20.3(128466)
45.7(289526)
19.2(121785)

GGT 23.9(151282)
GGC 9.8( 62157)
GGA 10.9( 69181)
GGG 6.0( 38293)
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1.8( 11103)

Appendix E: Additonal Methods

Spectrophotometric Determination of Lipase Activity using p-Nitrophenyl Laurate as
Substrate (Pinsirodom and Parkin 2006)
This method quantifies the level of p-nitrophenol (λmax 400 to 410 nm) released after the
hydrolysis of p-nitrophenyl laurate substrate by lipase. Lipase activity can be calculated by
comparing sample A410 values to those of a standard curve prepared with p-nitrophenol. While
p-nitrophenyl laurate is considered a model, synthetic substrate, it provides only a presumptive
test for lipase activity. The use of p-nitrophenyl acyl esters as chromogenic substrate analogs
provides for a continuous, spectrophotometric assay. This assay is an effective method for
sample screening or to provide an initial assessment of suitable assay conditions.
Cell Culturing. Yeast cells were prepared as follows: Single colonies were inoculated
into SD liquid media and grown overnight at 30°C and 300 rpm. Cell growth was measured by
optical density (OD) of the cultures at 600 nm on a spectrophotometer. The volume of culture
representing 25 OD units was calculated and transferred to a centrifuge tube. The cells were
then centrifuged for 10 minutes and 4000 rpm at 25 - 28oC. The supernatant was discarded. The
cells were resuspended in a small volume of synthetic galactose and transferred to 100 ml
synthetic galactose – 10 X URA media in a 500 ml flask (Cell density was .25OD/3 ml = 0.75
OD/ml).
Positive control assay. The p-nitrophenol standard curve was omitted because no p-nitrophenol
was available. Beer’s law and the extraction coefficient coupled with known information about
p-nitrophenol were used to produce a standard curve.
Spectrophotometric Lipase Assay. For each lipase activity, 2.5 ml of 0.1 M Tris⋅Cl buffer, pH
8.2 and 2.5 ml of 420 µM p-nitophenyl laurate substrate solution were combined in a 15 ml test
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tube. An extra test tube containing all reagents and 1 ml of water was prepared as a reagent
blank. The spectrophotometer was set to the Lip2_1 program, a Kinetics/Time program that
recorded A410 every 5 seconds for 5 minutes. 1 ml of the reagent blank was transferred to a
cuvette, then to the spectrophotometer. The instrument was set to blank. 1 ml of the lipase
solution was added to the next reagent containing solution to initiate the reaction. The mixture
was vortexed briefly and 1 ml of the reaction mixture was immediately transferred to a cuvette
then to the spectrophotometer. A410 was recorded every 5 seconds for 5 minutes. The reactions
using cell culture was performed in the same manner as the lipase solution. The graph and
resulting raw data were printed and saved. The p-nitrophenol standard curve was used to convert
absorbances to mM substrate hydrolyzed using the following formula; µmol p-nitrophenol/ml
reaction mixture = (A410 – y intercept)/ (slope x 6 ml reaction mixture). Lipase activity was
determined by constructing a reaction progress curve. A reaction progress curve was generated
using the concentration of p-nitrophenyl (mM) released versus reaction time
To optimize this reaction, several variations were employed. Instead of 0.1 M Tris⋅Cl
buffer, 0.5 M Tris⋅Cl, pH 6.8, (Okkels 1996), 0.1 M or 0.5M Tris⋅Cl, pH 7.2 (V. Newman,
personal communication 2003), were employed as part of the substrate mixture. In other trials
the cell cultures were centrifuged for 10 minutes at 14,000 rpm and the supernatant removed.
The supernatant fraction was used instead of cell culture.
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